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ABSTRACT
The specific activities of phosphofructokinase, aldolase, and
pyruvate kinase were diminished in crude extracts from skeletal
muscle of streptozotocin diabetic rats, whereas the activities of
glucosephosphate isomerase and phosphoglucomutase were not changed.
The decreased phosphofructokinase activity was shown to be
independent of allosteric control, and it could be reversed by insulin
treatment.

A rapid and mild method for the purification of phospho

fructokinase from rat skeletal muscle was developed.

The partially

purified enzyme from muscle of normal and streptozotocin diabetic
rats showed identical Michaelis constants for ATP and equal
sensitivity to inhibition by excess of ATP.

Extracts of quick-

frozen muscle from diabetic rats had higher levels of citrate, and
lower levels of fructose 1 ,6-bisphosphate and glucose 1 ,6-bisphosphate.
The levels of fructose 6-phosphate, glucose 6-phosphate, ATP, ADP,
and AMP were the same for the two groups.

These data suggest that

phosphofructokinase activity is decreased in muscle of diabetic animals
due to (a) a decrease in extractable activity, when assayed under
optimum conditions, and (b) an unfavorable change in the levels of some
of its allosteric modulators.
A precise and reproducible gas chromatographic procedure for
the determination of anomeric composition of glucose in biological
fluids was developed.

When applied to blood, peaks of the silylated

glucose anomers were well resolved and were the only two major
xii

peaks found in blood.

Blood glucose of normal and alloxan-diabetic

rats, fed or fasted, was found statistically to have an anomeric
composition slightly favoring the 3 anomer over the thermodynamic
equilibrium composition in water (39.1 + 0.6% a- and 60.9 + 0.6%
3-).

The anomeric composition of glucose in plasma as well as in

whole blood remained close to equilibrium after the administration
of insulin to normal or diabetic rats.

However, there was a

statistically noticeable decrease in the percentage of blood
3-glucose as a result of insulin treatment of normal animals.
A spin echo nuclear magnetic resonance technique for the noninvasive measurement of glycolytic activity in red blood cells from
normal and diabetic rats was used.
the two groups.

No differences were seen between

Proton magnetic resonance spectra of serum from

normal and diabetic rats were also similar.

xiii

CHAPTER I.

COMPARISON OF PHOSPHOFRUCTOKINASE ACTIVITY IN MUSCLE
OF NORMAL AND DIABETIC RATS

1

INTRODUCTION
Although the effect of experimental diabetes on liver phospho
fructokinase (PFK) (ATP:3-D-fructose 6-phosphate 1-phosphotransferase,
E.C. 2.7.1.11) has been studied by many groups, possible changes in
the muscle enzyme have attracted much less attention.

Abnormalities

in the control of PFK have been implicated in various organs of
diabetic animals (see below) as well as in other diseases (e.g.
muscular dystrophy (l) and tumor cells (2)).

The major means of

control of PFK activity are reviewed here, as are the known effects
of diabetes on PFK.

Some effects of glucagon are also discussed.

The PFK reaction is the first step unique to glycolysis, and has
been shown to be the rate limiting step in the glycolytic pathway (3).
PFK catalyzes the phosphorylation of fructose 6-phosphate at the
expense of ATP in an irreversible reaction, and produces fructose 1,6bisphosphate.

PFK has been shown to be highly specific for 3-fructose

6-phosphate (4-7), and is strongly regulated by various metabolites
(4,5,8).
PFK was first discovered in red blood cells in 1935 (9), and in
muscle in 1936 (10).

Seven

years after its

discovery, Cori (11)

suggested that PFK was the rate limiting step in glycolysis.

Since

then, PFK has been shown to be responsible, at least in part, for the
Pasteur effect (12), and for the oscillations in the levels of
pyridine nucleotides in cells exhibiting glycolytic activity (13).

3

Mechanisms for controlling PFK activity have been the subject
of many investigations.

PFK's activity has been shown to be "affected

by allosteric means, association-dissociation, and possibly, by
covalent modification, as well as by variations in the concentration
of enzyme.
Control of PFK:
By allosterism.

The velocity of the PFK reaction is known to

increase in a hyperbolic fashion with increasing substrate concentra
tion (ATP or fructose 6-phosphate) when measured at pH 8.0 (4).

At

physiological pH, however, PFK shows complex kinetic behavior, in
that the enzyme velocity increases in a sigmoidal manner with
increasing fructose 6-phosphate concentration.

PFK was first shown, in

1956, to be inhibited by high levels of its substrate, ATP, when
measured at physiological pH (14).

This inhibition could be overcome

by increasing the concentration of fructose 6-phosphate, or by the
addition of AMP, cyclic AMP, ADP, glucose 1,6-bisphosphate, fructose 1,6bisphosphate or ammonium ions (15-19).

PFK was found to be inhibited

by phosphoenolpyruvate, phosphocreatine, 3-phosphoglycerate, 2-phosphoglycerate, and 2,3-bisphosphoglycerate (20), citrate (21), cyclic
GMP (22), and by low pH (6.9) (23).
For the purposes of this report, conditions under which PFK has
been shown to exhibit complex kinetic behavior have been termed
"allosteric conditions", and conditions under which PFK behaves
according to Michaelis-Menten kinetics are "non-allosteric conditions".
It has been suggested that allosteric regulation of PFK involves
two tetrameric forms of PFK which are in rapid equilibrium, and differ

by their degree of protonation (24,25).

Using intrinsic protein

fluorescence and binding measurements, Pettigrew and Frieden (25)
showed that positive effectors (those which reverse ATP inhibition of
PFK) bind the deprotonated, or active, form of PFK, Whereas
negative effectors bind, and thus stabilize, the protonated (inactive)
form.

Rro forms of rabbit muscle PFK were also seen by Mathias and

Kemp (26), based on the reactivity of one specific thiol group.
Positive effectors of PFK increased-the reactivity of the thiol group,
and ATP decreased this reactivity.

Jones et al. (27) showed two

conformations of rabbit muscle PFK by monitoring spin-labeled PFK by
ESR.

The spin label, covalently bound to sulfhydryl groups of PFK,

was decreased in mobility when ATP was bound to PFK, suggesting that
the spin label was becoming more buried

as PFK was undergoing a

conformational change.
By association-dissociation.
activity at low pH (6.7) (28).

ATP was shown to stabilize PFK

However, in the absence of ATP, PFK

underwent a slow inactivation, as determined by residual PFK activity
(non-allosteric conditions).

Lad et al. (29) correlated rabbit muscle

PFK activity with the aggregation state of the enzyme, and showed
that fructose 6-phosphate and fructose 1 ,6-bisphosphate (activators of
PFK) stabilized a tetrameric form of PFK, whereas citrate (inhibitor
of PFK) stabilized a dimer form.

In contrast to citrate, ATP (PFK

inhibitor) did not depolymerize PFK.

The tetrameric form of rabbit

muscle PFK could also be stabilized by high pH (8.0) (30), with
dissociation occurring at physiological pH, or at low protein concen
tration ( < 0.2 mg/ml), as determined by frontal gel chromatography.
Polymerization effects similar to those for muscle enzyme have been

demonstrated for PFK from liver (31).
By covalent modification.

In contrast to the well known cyclic

AMP dependent phosphorylation of phosphorylase b (E.C. 2.4.1.1) and
pyruvate kinase (E.C. 2.7.1.40)* PFK has not been shown to undergo a
reversible covalent modification with an accompanying activationdeactivation of the enzyme.

However* Kagimoto and Uyeda (32) have

recently shown a glucagon-mediated phosphorylation of liver PFK which
resulted in increased sensitivity to ATP inhibition under allosteric
conditions.

In 1975, Brand and Soling (33) reported an activation-

deactivation mechanism for liver PFK by phosphorylation-dephosphorylation, but these authors later withdrew their claims that the phosphor
ylation affected enzyme activity (34).

Hofer and Furst (35)

demonstrated an Jji vivo phosphorylation of skeletal muscle PFK* but
did not show any change in PFK activity.

These demonstrations of

phosphorylation of PFK suggest a possible covalent modification of PFK
in vivo; however whether or not this modification of PFK plays an
important role in the regulation of PFK activity is presently unknown.
Effect of diabetes on P F K :
From muscle.

Little work has been done to describe the effects of

diabetes on PFK from any specific type of muscle; however data are
available to suggest that there should be a decrease in PFK activity
in several muscle types (heart* skeletal* diaphragm) in diabetic
animals.

In 1961* Newsholme and Randle (36) reported a decreased ratio

of fructose 1 ,6-bisphosphate/fructose 6-phosphate in perfused hearts
from alloxan diabetic rats* indicating decreased PFK activity.
Newsholme and Randle later showed that perfusion of normal rat hearts
with fatty acids or ketone bodies also depressed PFK activity (37)*

and suggested that the increased levels of fatty acids and ketone
bodies which occurred in diabetes inhibited PFK by allosteric means.
Inhibition of PFK was not a direct effect of the increased levels of
fatty acids and ketone bodies, but was due to a concurrent
increase in the level of citrate, as shown by Parmeggiani and
Bowman (38).

Citrate, a PFK inhibitor, was increased in concentration

in hearts perfused with fatty acids or ketone bodies, and in hearts
from diabetic animals » and their treatment with insulin
reduced the levels of citrate.

Physiological levels of citrate, but

not of fatty acids or ketone bodies, were shown to inhibit PFK in vitro
and therefore, it was suggested that the depressed PFK activity in
hearts of diabetic rats was due to increased catabolism of lipids
(resulting in increased levels of citrate) in the diabetic animal (38).
The effect of diabetes on PFK in heart muscle was further studied
by Regen et al . (39), who confirmed decreased PFK activity in perfused
hearts of diabetic rats.

By measurement of the levels of fructose 6-

phosphate, fructose 1 ,6-bisphosphate, nucleotides, and inorganic phos
phate, they showed that PFK inhibition in the perfused heart of diabetic
rats could be overcome by anoxia.

Diabetes did not affect the levels

of ATP, ADP, AMP, or inorganic phosphate in heart muscle, but anoxia
resulted in decreased ATP (PFK inhibitor) and increased levels of
AMP, ADP, and inorganic phosphate (PFK activators).

Thus, anoxia

could reverse the inhibition of PFK in perfused hearts from diabetic
rats by allosteric means.
Using a radioimmunoassay technique, Hansen and Veneziale (40)
measured the concentration of PFK in extracts prepared from the left
ventricle of rabbit heart and from skeletal (antibial) muscle from

normal and alloxan diabetic rabbits.

These authors detected no

differences In the concentration or activity of muscle PFK, and
suggested that the control at the PFK step was due to allosteric
effects, rather than to insulin mediated changes in the intracellular
enzyme.
On the other hand, Ianuzzo and Armstrong (41) showed a decrease
in the specific activity of PFK in extracts prepared from skeletal
muscle of streptozotocin diabetic rats.

Specific activity of PFK was

decreased in muscle extracts from diabetic animals, when prepared
from three different fiber types:

slow twitch, oxidative (soleus

muscle), fast twitch, oxidative, glycolytic (axial gastrocnemius), and
fast twitch, glycolytic (peripheral gastrocnemius).

The cause of the

decreased PFK activity was not investigated.
PFK was the rate limiting step in the metabolism of glucose in
perfused frog muscle when glycogenolysis was stimulated by epinephrine
(42), in that glycogen was broken down to hexose monophosphates, but
little lactate was produced.

When insulin was added to the perfusion

medium, however, the levels of hexose monophosphates decreased, and
lactate was produced, indicating a stimulation of PFK activity by
insulin.
Taunton et al. (43) also showed a rapid effect of insulin on
skeletal muscle PFK.

In experiments where rats were injected (intra

venous) with insulin In situ, then the muscle was excised and the PFK
was extracted, the specific activity of PFK was increased (assayed under
under allosteric conditions, pH 7.4).

This effect of insulin was

maximal at 5-10 min following insulin treatment, suggesting a short
term, insulin mediated effect on muscle PFK.

Beitner et al. (44) demonstrated an Insulin-mediated effect on
PFK activity in rat hemidiaphragm, and showed that this effect was
independent of glucose transport.
with

14

Hemidiaphragms were preloaded

C-glucose, then incubated in a glucose-free medium with or

without Insulin.

Using fast-freezing techniques, these authors

demonstrated increased levels of fructose 1 ,6-bisphosphate in diaphragms
which had been incubated with insulin, indicating increased PFK
activity.

In another experiment, diaphragms were incubated with or

without insulin, and the levels of glucose in the medium were adjusted
so that the rate of glucose uptake was less in the insulin-treated
diaphragms.

These experiments showed increased Incorporation of

radioactivity from

14

G-glucose into carbon dioxide and triglyceride

glycerol for the insulin-treated diaphragms, indicating increased
metabolism of glucose, independent of glucose transport.
From liver.

Taunton et al. (45) showed rapid (within 4 min)

increases in liver PFK activity in response to insulin.

When rats

were injected (intravenously) with insulin in situ, then the livers
excised and the enzymes extracted, activity of PFK and of pyruvate
kinase was increased, whereas activity of fructose bisphosphatase (E.C.
3.1.3.11) was decreased.

On the other hand, glucagon decreased the

activities of PFK and pyruvate kinase, and increased fructose bis
phosphatase activity.

Later studies showed these effects to be

independent of de novo synthesis, as treatment with Actinomycin D or
puromycin had no effect on the results of these experiments (43).
In addition to the short term effects demonstrated by Taunton
et al.> a long term effect of insulin on PFK from liver was demonstrated
by Weber and Singhal (46).

PFK activity in liver could be increased

by insulin treatment, and this increase in activity could be blocked by
actinomycin or ethionine.

The mechanism of this effect was studied

by Dunaway and Weber (47), who reported a decrease in the concentration
of the major isozyme of PFK in the liver of diabetic rats.

Using a

double isotope technique and an immunoassay for the major (I^)
isozyme of PFK in liver, these authors showed an increase in the rate
of degradation of the PFK
alloxan diabetic rats.

isozyme in the liver of streptozotocin or

Insulin treatment, on the other hand, resulted

in increased synthesis and decreased degradation of the
of PFK.

isozyme

Dunaway and Segal (48) later discovered that the levels of

the L2 PFK isozyme were controlled, in part, by a PFK protective
factor.

The level of this factor was decreased in the liver of

diabetic rats, and could be increased by insulin treatment.

Thus, the

half life for the Lg isozyme of PFK in liver was decreased from 1.8
days, for normal rats, to 0.6 days, for diabetic rats, due to
decreased levels of the protective factor (49).

The protective factor

was determined to be a polypeptide of 3500 daltons, consisting of
equimolar glutamate, glycine, and half-cystine (50).

In addition to

its protective effects on purified liver PFK, the factor was shown to
activate PFK by facilitating binding of fructose 6-phosphate.
Hosey et al. (51) also studied the major PFK isozyme (I^) in the
livers of normal and genetically diabetic mice, and showed increased
sensitivity to ATP for the enzyme from diabetic animals.

The diabetic

animals were hyperglucagonemic, and these authors attributed the
increased ATP sensitivity to a glucagon-dependent regulation of PFK.
From lens.

The activity of PFK was decreased in the lens of the

alloxan diabetic rat, as evidenced by a decrease in the fructose 1 ,6-

bisphosphate/fructose 6-phosphate ratio (52).

The resulting decreased

glycolytic flux was responsible for decreased production of ATP in
lens, according to the authors.

Levels of AMP, cyclic AMP, and ADP

were unchanged in the lens of the diabetic rat.
From renal cortex and epididymal fat.

Insulin treatment of renal

cortex or epididymal fat in situ resulted in increased PFK activity in
the rat (43).

After insulin treatment, the organ was excised, and the

PFK was extracted and assayed.

The effects of insulin were maximal in

5-10 min, suggesting a mechanism other than de novo synthesis of PFK.
From 3T3 cells.

Addition of insulin to quiescent cultures of 3T3

cells enhanced PFK activity in homogenates prepared from the cells (53)
This increased PFK activity occurred in the cells with or without
concurrent treatment with cycloheximide, indicating that de novo
synthesis of PFK was not involved.

Since the increased activity

persisted whether the enzyme was assayed under allosteric (pH 7.4) or
non-allosterlc conditions (pH 8.2), the authors suggested that an
activation of preexisting inactive PFK was responsible for the insulin
effect.
Effect of glucagon on PFK.

Recently, several effects of glucagon

have been demonstrated for regulation of liver PFK.

Although these

effects have not been implicated in the altered regulation of PFK in
diabetic animals, they are important in regard to diabetes because of:
a)

the known antagonistic effects of insulin and glucagon, and b)

the abnormally high ratio of glucagon/insulin in the serum of diabetic
animals.
Treatment of perfused liver with glucagon resulted in the
decreased production of a low molecular weight activator of PFK (54-57)

This activator, isolated from liver cells and identified as
fructose 2,6-bisphosphate, could stimulate PFK at extremely low
concentrations (0.1 pM) (54).

It was suggested, therefore that

decreased PFK activity in glucagon-treated liver cells was due to
decreased amounts of this activator.

The presence of this activator

has not been demonstrated in muscle, as yet.
Increased phosphorylation of liver PFK in glucagon-treated
perfused liver has been demonstrated by Kagimoto and Uyeda (32).

The

phosphorylated PFK had decreased inhibition constants for ATP and
citrate, resulting in increased sensitivity to inhibition by these
effectors.

Furuya and Uyeda (58) also demonstrated a phosphorylation

of PFK> concurrent with increased ATP sensitivity, and showed that
the increased ATP inhibition was not due directly to the phosphor
ylation of PFK, but to a decreased affinity of phosphorylated PFK for
an activation factor (59).

The activation factor was purified, and'

shown to be carbohydrate in nature.
Purpose of this investigation.

The above mentioned studies

indicate that PFK activity is decreased in the diabetic state.

Studies

on skeletal muscle PFK have not been conclusive, however, in that
Hansen and Veneziale (40) found no difference in the concentration or
activity of PFK in the muscle of diabetic animals, whereas Ianuzzo and
Armstrong (41) showed decreased PFK activity.

In addition, the mech

anism^) of decreased PFK acitivity in skeletal muscle have not been
investigated.
1.

Therefore, the purpose of this study was to:

Determine whether or not PFK activity was decreased in the
skeletal muscle of diabetic animals; and

2.

If PFK activity was found to be decreased, investigate the

nature of the altered PFK activity.
Rats were used In this investigation because of the large number
of animals needed for each experiment for statistical analysis of the
data.

Little work has been done on rat muscle PFK, and therefore, this

report includes experiments which probe the properties of rat muscle
PFK at various stages of purification.

METHODS
Assay of PFK activity.

Activity of PFK was measured by coupling

the PFK reaction to either a ADP system, or to a fructose 1,6-bisphosphate system.

For the ADP-coupled system, assay mixtures contained

0.04 M buffer (tris chloride, pH 7.8, or imidazole chloride, pH 7.2)
4.0 mM magnesium chloride, 0.02 mM EDTA, 1.0 mM dithiothreitol,
2.0 mM phosphoenolpyruvate, 0.16 mM NADH, 0.5 mM ATP, one unit of each
of pyruvate kinase (E.C. 2.7.1.40) and lactate dehydrogenase (E.C.
1.1.1.27), and 1.0 mM fructose 6-phosphate.

The fructose 1,6-bisphos-

phate-coupled assay was according to the method of Ling et al. (60), and
consisted of 0.05 M buffer (tris chloride, pH 7.8, or imidazole chloride
(pH 6.7 or 7.2),

0.05 M potassium chloride, 5.0 mM magnesium sulfate,

1.0 mM dithiothreitol, 0.16 mM NADH, 0.5 mM ATP, 0.1 unit of aldolase
(E.C. 4.1.2.13), 0.6 unit of glycerol 3-phosphate dehydrogenase (E.C.
1.1.1.8), 6 units of triose phosphate isomerase (E.C. 5.3.1.1), and
1.0 mM fructose 6-phosphate.

Assays contained 1 to 4 munits of PFK

activity, and were initiated by the addition of fructose 6-phosphate.
The change in absorbance at 340 nm was measured using a Gilford
model 250 spectrophotometer, and recorded on a Gilford model 6051
recorder.

One unit of activity was defined as the amount of enzyme

that would catalyze the production of 1.0 nmole of fructose 1 ,6-bisphosphate per min at 28°C.
Preparation of crude muscle extract. Rats were killed by decapi
tation, and muscle from the back and hind legs was excised and placed
13
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In Ice.

Crude extracts were prepared by a modification of the method

of Ling et al. (61):

muscle (5 - 10 g, or 100 g if PFK was to be

purified) was homogenized for 1 min with 3 volumes of 0.03 M potassium
fluoride, 1.0 mM EDTA at 0 - 4°C, then centrifuged in a Sorvall RC2-B
centrifuge (SS-34 rotor) for 1 hr at 1300 x g, followed by centrifu
gation at 10,000 x g at 0 - 4°C.

In experiments where PFK activity

was measured at timed intervals following preparation of the crude
extract, centrifugation was in an Eppendorf model 5412 centrifuge for
10 min at 13,000 x g and 0 - 4°C.

In these experiments, other buffers

were substituted for the potassium fluoride, EDTA buffer, as indicated.
Partial purification of rat muscle PFK.
Preparation of the resuspended 104,000 x g pellet.

Crude muscle

extract (156 ml) was centrifuged for 2 hr at 104,000 x g in a Beckman
L5-75 centrifuge (Ti-75 rotor) at 0 - 4°C.

The pellet, containing

the PFK activity> was resuspended using a teflon tissue homogenizer,
in 0.1 M tris phosphate, pH 8.0, 0.2 mM EDTA, 5.0 mM 2-mercaptoethanol
(other buffers were used in some experiments, as indicated).
Reactive Blue 2-Agarose chromatography.

The resuspended 104,000

x g pellet was dialyzed overnight against 2 x 500 ml of 0.1 M tris
phosphate, pH 8.0, 0.2 mM EDTA, 5.0 mM 2-mercaptoethanol.

The dialyzed

sample was diluted with one volume of dialysis buffer, then applied to
a 1.5 x 18 cm column bed of Reactive Blue 2-Agarose (Sigma), previously
equilibrated with 0.1 M tris phosphate, pH 8.0, 0.2 mM EDTA.

The

column was washed with 160 ml of equilibrating buffer, then the PFK
activity was eluted using a non-linear gradient, constructed from 125
ml of equilibrating buffer in a 150 ml beaker, and 125 ml of equili
brating buffer, 1.25 M in ammonium sulfate, in a 125 ml Erlenmeyer
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flask, and connected to the beaker by a salt bridge.

Active fractions

were pooled (65 ml), and concentrated to 15 ml by ultrafiltratlon
(Amlcon, PM-10 membrane).

Partially purified PFK, prepared in this

manner, was stable for many weeks.
Activation of PFK by MgATP.

Crude or partially purified PFK was

incubated with 1 volume of 0.05 M tris chloride containing 0.01 M ATP
and 0.01 M magnesium chloride, pH 7.8.
after 20 min of incubation at 28°C.

PFK activity was measured

These conditions allow

for the complete activation of PFK, as determined earlier (62).
Protein determination.

Protein was measured by the method of

Lowry et al. (63), using 0.1 per cent lysozyme (Boehringer) as a
standard.
Sodium dodecyl sulfate gel electrophoresis.

Polyacrylamide gels

were prepared as described by Weber and Osborn (64) for sodium dodecyl
sulfate-tris gels, 7.5 per cent in polyacrylamide.

Samples containing

30 - 80 yg of protein, 5 per cent in glycerol, and containing bromphenol blue as a tracker dye, were layered under the reservoir buffer.
After running at 5 - 8 ma per gel (approximately 8 hrs), gels were
stained overnight in Coumassie blue.
Induction of diabetes in animals.

Sprague-Dawley rats were made

diabetic by the injection of streptozotocin (Sigma, 65 mg per kg of body
weight) into the tail vein at least one week prior to use.

All

diabetic rats used in this study had blood glucose in excess of 200 mg
per 100 ml.
Blood glucose determination.

Restrained rats were warmed for a

few min with a heating mantle, then 1 cm of the tail was excised.
Heparinized blood samples (20 pi) were measured into 100 yl of

distilled water, and were made protein free by a modification of
the method of Somolygi (65) as follows:

40 yl of 0.1 N barium

hydroxide was added to each sample with mixing.

After 5 min, 40 yl

of 1.7 per cent zinc sulfate heptahydrate was added with mixing, and
after 5 min, the samples were centrifuged.

Glucose was measured

according to the method of Okuda et al. (66), using 0.1 per cent
glucose as a standard.
Assay of enzymes other than PFK.

All auxilliary enzymes used

in these experiments were purchased from Sigma.

Crude muscle extracts

and auxilliary enzymes were dialyzed exhaustively before use (0.1 M
tris phosphate, pH 8.0, 0.2 mM EDTA, 5.0 mM 2-mercaptoethanol), and
enzyme activities were measured at 28°C.
used for the assay of enzymes:

The following methods were

phosphoglucomutase (E.C. 2.7.5.1),

Najjar (67); glucosephosphate isomerase (E.C. 5.3.1.9), Noltman (68);
pyruvate kinase (E.C. 2.7.1.40), Bucher and Pfleiderer (69); and
fructose bisphosphatase (E.C. 3.1.3.11), Pontremoli (70).

Aldolase

(E.C. 4.1.2.13) assays consisted of 0.04 M imidazole chloride, pH 7.5,
1.0 mM dithiothreitol, 0.16 mM NADH, 0.1 unit of glycerol 3-phosphate
dehydrogenase, and 1.0 unit of triose phosphate isomerase.

The

reaction, containing approximately 0.01 unit of aldolase activity, was
begun by the addition of fructose 1,6-bisphosphate (1.0 mM, final
concentration).

Phosphorylase (E.C. 2.4.1.1) was measured by the

production of glucose 1-phosphate from glycogen.

Assay mixtures

contained 0.16 M potassium phosphate, pH 6 .8, 13.2 mM magnesium
chloride, 1.0 mM AMP, 0.16 mM NADP+ , 0.8 per cent glycogen (Sigma),
4.0 yM glucose 1,6-bisphosphate, 3 units of each of phosphoglucomutase
and glucose 6-phosphate dehydrogenase (E.C. 1.1.1.49), and a sample

containing approximately 0*01 unit of phosphorylase b.
was started by the addition of the sample.

The reaction

Assays without glycogen

or without phosphorylase served as controls.
For the measurement of the pH optimum of aldolase, reactions
contained 0.05 M buffer (tris chloride or imidazole chloride, variable
pH), 0.05 M potassium chloride, 5.0 mM magnesium sulfate, 1.0 mM
dithiothreitol, 0.16 M NADH, and auxilliary enzymes (0.1 unit of
glycerol 3-phosphate dehydrogenase and 1.0 unit of triose phosphate
isomerase).

The reaction was started by the addition of 1.0 mM

fructose 1,6-bisphosphate (final concentration).

To determine the

pH optimum of pyruvate kinase, assay mixtures consisted of 0.05 M
buffer (tris chloride or imidazole chloride, variable pH), 0.05 M
potassium chloride, 4.0 mM magnesium chloride, 0.02 mM EDTA, 1.0 mM
dithiothreitol, 2.0 mM phosphoenolpyruvate, 0.16 mM NADH, and 0.1
unit of lactate dehydrogenase.

The reaction was started by the

addition of 0.5 mM ADP (final concentration).

Lactate dehydrogenase

assays contained 0.05 M buffer (tris chloride or imidazole chloride,
variable pH), 0.16 mM NADH, 0.05 M potassium chloride, 4.0 mM
magnesium chloride, 0.02 mM EDTA, 1.0 mM dithiothreitol, approximately
0.01 unit of lactate dehydrogenase (Sigma), and 1.0 mM pyruvate
(added to start the reaction).

For measurement of the pH optimum of

glycerol 3-phosphate dehydrogenase, assays contained 0.05 M buffer
(tris chloride or imidazole chloride, variable pH), 0.05 M potassium
chloride, 5.0 mM magnesium sulfate, 1.0 mM dithiothreitol, 0.16 mM
NADH, 2.0 units of aldolase, 0.1 unit of triose phosphate isomerase,
approximately 0.01 unit of glycerol 3-phosphate dehydrogenase (Sigma),
and 1.0 mM fructose 1,6-bisphosphate (final concentration, added to
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8tart the reaction.
Preparation of flash-frozen muscle samples.

Rats were

anesthetized with ether, and the skin was dlsected away from the leg
and back area.

Muscle samples (1 - 6 g) were quickly excised (In less

than 7 sec) and frozen In liquid nitrogen.

The frozen samples were

pulverized using a stainless steel mortar and pestle in dry ice,
and stored at -70°C until use.

Extracts were prepared from the quick-

frozen muscle samples by a modification of the method of Lowry et al.
(71), as follows:

the samples were quickly weighed into a cold (dry

ice) 50 ml polyethylene centrifuge tube in the cold room, then 9.0 ml
of ice cold 3.0 M perchloric acid was added with mixing.

After 10 min,

30 ml of ice cold 1.25 M EDTA was added with mixing (10 min), after
which the samples were centrifuged at 10,000 x g for 20 min at 0 - 4°C.
The supematents were poured into 9.0 ml of ice cold 3.0 M sodium
carbonate.

Samples were centrifuged again at 10,000 x g for 20 min,

and the supematents were stored at -20°C until use.
Assay of metabolites in flash-frozen muscle.

Measurement of

glucose 6-phosphate, fructose 6-phosphate, fructose 1 ,6-bisphosphate,
ATP, ADP, and AMP were from the fluorimetric methods of Lowry et al.
(71).

An eppendorf photometer, equipped with a fluorescence attachment,

was used in these determinations, with a 313 - 366 nm excitation
filter and a 380 - 3000 nm secondary filter.

All enzymes used in

these measurements were dialyzed (0.1 M tris phosphate, pH 8.0, 0.2
mM EDTA, 5.0 mM 2-mercaptoethanol) prior to use.

Fluorescence grade

imidazole was purchased from Sigma.
Assay of glucose 1,6-bisphosphate was from the phosphoglucomutase
velocity method described by Passonneau e£ al . (72).

Assay mixtures

contained 0.04 M imidazole chloride, pH 7.4, 2.0 mM magnesium chloride,
0.2 mM EDTA, 0.04 mM NADP , 1.6 units of glucose 6-phosphate dehydro
genase, 0.01 unit of phosphoglucomutase, and 5-10 yl of muscle extract
(adjusted to pH 7.4).

The reaction was started by the addition of

0.015 mM glucose 1-phosphate (final concentration), and the phospho
glucomutase velocity was recorded spectrophotometrically (340 nm).
A standard curve was constructed, using 30 - 200 yl of 0.2 yM
glucose 1 ,6-bisphosphate.
Citrate was measured by the method

of S t e m (73), with muscle

extract samples representing 1.0 to 1.5g of muscle.
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P nuclear magnetic resonance spectroscopy.

Extracts prepared

from quick frozen muscle from normal or diabetic rats were pooled,
passed through a Chelex 100 (Bio-rad) cation exchange column (sodium
counter ion), and concentrated to 10 per cent of the original volume
(measured pH of both samples was

10.0). Nuclear magnetic resonance

spectroscopy was on a Bruker WP 200 spectometer, operating at 80.8
megahertz, with broadband proton decoupling.
reported relative to external phosphoric acid.

Chemical shifts were

RESULTS
Kinetic analysis of PFK in crude muscle extracts.

Crude

muscle extracts were desalted by passage through Sephadex G-25,
previously equilibrated with 0.1 M potassium phosphate, pH 8.0, 1.0
-mM EDTA, 5.0 mM 2-mercaptoethanol, and were used within 3 hrs of
desalting.

Fig. 1 shows that, at a fructose 6-phosphate concentration

of 0.5 mM, PFK velocity was maximal at an ATP concentration of 0.5 mM
(pH 7.8 or 6.7).

No ATP inhibition was apparent at pH 7.8, but crude

muscle PFK showed sensitivity to ATP inhibition at pH 6.7.

Rough

estimates of the Michaelis constants for ATP could be obtained from
double reciprocal plots of the data, giving a Km of 0.14 mM at pH 7.8,
and 0.31 mM at pH 6.7.

Crude muscle extract showed hyperbolic

behavior with increasing fructose 6-phosphate concentration at pH 7.8,
and sigmoidal behavior at pH 6.7 (Fig. 2).

When ATP concentration

was 0.5 mM, PFK velocity was maximal at 1.0 mM fructose 6-phosphate
(pH 7.8 or 6.7), indicating the enzyme assay described under METHODS
was measuring PFK activity at maximal velocity in crude muscle extracts.
Michaelis constants for fructose 6-phosphate were calculated to be 0.13
mM (pH 7.8, from a double reciprocal plot of the data), and 0.7 mM
(pH 6.7, from the substrate concentration when velocity is half the
maximal velocity ).
Effect of extraction buffer on the stability of PFK in crude
muscle extracts.

Fig. 3 shows the activity of PFK in crude extracts

from rat muscle, prepared using various buffer systems.
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In three of

FIG. 1.

Velocity of PFK in desalted crude muscle extract at

varying concentrations of ATP.

The fructose 1,6-bisphosphate-coupled

assay was used in these determinations, and the fructose 6-phosphate
concentration was 0.5 mM.
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FIG. 2.

Velocity of PFK in desalted crude muscle extract at varying

concentrations of fructose 6-phosphate.

The fructose 1,6-bisphosphate

coupled assay was used in these determinations, and the ATP
concentration was 0.5 mM.
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FIG. 3.

Stability of muscle PFK in crude extracts when extracts

were prepared with the following buffer systems:

(o) 0.03 M

potassium fluoride, 1.0 mM EDTA; (x) 0.1 M potassium phosphate, pH 7.8,
0.1 M ammonium sulfate, 0.5 mM magnesium chloride, 5.0 mM 2-mercaptoethanol; (•) 0.02 M tris chloride, pH 7.5, 0.12 M potassium chloride,
0.1 mM EDTA; (■) 0.02 M tris chloride, pH 7.5, 0.12 M potassium
chloride, 0.1 mM EDTA, 0.5 mM magnesium chloride; (A) 0.25 M sucrose.
Hie activity of PFK in the crude muscle extracts was assayed by the
ADP-coupled method at pH 7.8, as described in METHODS.
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the five buffer systems tested (0.1 M potassium phosphate, pH 7.8,
0.1 M ammonium sulfate, 0.5 mM-magnesium chloride, 5.0 mM 2-mercapto
ethanol; 0.02 M tris chloride, pH 7.5, 0.12 M potassium chloride, 0.1
mM EDTA; and 0.2 M tris chloride, pH 7.5, 0.12 M potassium chloride,
0.1 mM EDTA, 0.5 mM magnesium sulfate), PFK activity was rapidly lost
after preparation of the extract.

On the other hand, activity of

extracts prepared with 0.03 M potassium fluoride, 1.0 mM EDTA retained
more than 95 per cent of the original PFK activity.

By extrapolation

of the PFK activity to time = 0 hr, four of the five preparations had
similar activities at the beginning of the assay period.

The fifth

preparation (prepared with 0.25 M sucrose) had little PFK activity
throughout the experiment.

The activity of PFK which was lost in

three of the crude muscle extracts could be restored by activation
with MgATP, as described in METHODS (Fig. 4).
The measured pH of the crude extracts in Fig. 3 was 6.4 to 6.7,
indicating that PFK in the potassium fluoride, EDTA system was stabil
ized by some factor other than pH.

In another experiment, however,

stability of PFK was dependent on the pH of the muscle homogenate
(Fig. 5).

When the pH of the crude muscle homogenate was adjusted to

8.7, PFK in the resulting muscle extract was stable (pH of the extract
was 7.8 after 5 hrs of storage, and the extraction buffer was 0.02 M
tris chloride, pH 7.5, 0.12 M potassium chloride, 0.1 mM EDTA).

If

the muscle homogenate was adjusted to pH 7.9 or 7.0, however, PFK
activity was rapidly lost (resulting crude extracts were pH 6.8 and
pH 6.5 after 5 hrs of storage, respectively).

The activity of PFK

could be restored by activation with 5.0 mM MgATP (Fig. 6 ).
Effect of dialysis on PFK activity in crude muscle extracts.

FIG. 4.

Activity of muscle PFK in crude extracts when prepared

with various buffer systems, then activated with 5.0 mM MgATP before
assay.

The buffer systems were the same as in FIG. 3.
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FIG. 5.

Stability of PFK in crude muscle extracts of varying pH.

Hie extraction buffer was 0.02 M tris chloride, pH 7.5, 0.12 M
potassium chloride, 0.1 mM EDTA, and the pH of the homogenates were
adjusted prior to centrifugation.

The measured pH of the extracts

were (o) 6.5, (x) 6 .8 , and (•) 7.8 after 5 hrs of storage.
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FIG. 6 .

Activity of PFK in crude extracts of varing pH when

activated with 5.0 mM MgATP before assay.

The extraction buffer was

0.02 M tris chloride, pH 7.5, 0.12 M potassium chloride, 0.1 mM EDTA,
and the pH of the extracts prior to the activation step were (o) 6.5,
(x) 6 .8 , and (•) 7.8.
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Muscle extracts, prepared with 0.03 M potassium fluoride, 1.0 mM EDTA,
were dialyzed against various buffer systems.

Table I shows a loss

of PFK activity with every buffer system tested.

Potassium fluoride

(30 mM) did not prevent Inactivation of PFK during dialysis.

Magnesium

chloride at a concentration of 0.5 mM appeared to stabilize the PFK
activity somewhat, but a higher concentration (5.0 mM) resulted In loss
of PFK activity.

The product of the PFK reaction, fructose 1,6-

bisphosphate, did not prevent inactivation of PFK, nor did the
substrate, ATP (5.0 m M ) .

The buffer system providing the greatest

stabilizing effect for dialysis of crude muscle extracts contained
0.1 M potassium phosphate, pH 8.0, 0.1 M ammonium sulfate, 0.5 mM
magnesium chloride, and 5.0 mM 2-mercaptoethanol.
Effect of dilution buffer on PFK activity in crude muscle
extracts.

Crude muscle extracts were prepared, using 0.03 M potassium

fluoride, 1.0 mM EDTA, and diluted 1:9 (v/v) with various buffer
systems.

After 4 hrs of incubation at 0 - 4°C, the diluted crude

extracts were tested at pH 7.8 for PFK activity.

Fig. 7 shows

retention of activity (more than 90 per cent) when the dilution buffer
was 0.1 M tris phosphate, pH 8.0, 0.2 mM EDTA.

Dilution with the

extraction buffer (0.03 M potassium fluoride, 1.0 mM EDTA) resulted in
a loss of 25 per cent of the PFK activity, and if the extraction
buffer was 5.0 mM in ATP, more than 50 per cent of the activity was
lost.

The other buffers tested (0.2 M imidazole chloride, pH 6.7;

imidazole chloride, pH 7.3; and tris chloride, pH 7.8) and water,
resulted in approximately 25 per cent loss of PFK activity.
In another experiment, various dilutions of crude muscle extract
were made with 0.03 M potassium fluoride, 1.0 mM EDTA.

Fig. 8 shows

TABLE I
LOSS OF PFK ACTIVITY IN CRUDE MUSCLE EXTRACT
BY DIALYSIS IN VARIOUS BUFFER SYSTEMS

Treatment

Per cent PFK activity

None

100

Dialysis against 0.1 M potassium phosphate, pH 8.0

12

+ 5.0

mM

2-mercaptoethanol

9

+ 4.0

mM

magnesium chloride

0

+ 30 mM potassium fluoride

9

+ 0.2

mM

fructose 1,6-bisphosphate

6

+ 0.2

mM

EDTA

9

Dialysis against 0.1 M potassium phosphate, pH 8.0,
5.0 mM 2-mercaptoethanol, 0.1 M ammonium sulfate,
0.5 mM magnesium chloride

74

- 0.5 mM magnesium chloride

57

- 0.1 M ammonium sulfate

65

+ 4.5 mM magnesium chloride

28

Dialysis against 0.1 M tris phosphate, pH 8.0,
0.2 mM EDTA, 5.0 mM ATP

41

FIG. 7.

Activity of PFK in crude muscle extracts when diluted 1:9

(v/v) in various buffer systems, and incubated at 0 - 4°C for 4 hrs.
The results are expressed relative to extract which was diluted
with 0.1 M tris phosphate, pH 8.0, 0.2 mM EDTA just before assay,
and are the average of two experiments.
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FIG. 8 .

Specific activity of PFK in crude muscle extract when

diluted with extraction buffer and incubated at 0 - 4°C for 5 hrs.
Activity is expressed as the per cent of specific activity of the
undiluted extract.
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that a slight dilution (8:2, crude extractrbuffer) resulted in
increased PFK activity.

Further dilutions of crude muscle extract

did not affect PFK activity until crude extract represented only 40
per cent of the volume, after which PFK activity was lost with dilution.
Effect of desalting and dilution of PFK activity in crude muscle
extracts.

Crude muscle extract was desalted by passage through a

1.5 x 30 cm Sephadex G-25 column which had been previously equilibrated
with 0.1 M potassium phosphate, pH 8.0, 1.0 mM EDTA, 5.0 mM 2-rmercaptoethanol.

The protein fractions were pooled and diluted (1:0, 1:1, 1:4,

and .1:9, v/v) with buffer (0.1 M tris phosphate, pH 8.0, 0.2 mM EDTA,
5.0 mM 2-mercaptoethanol, 0.1 per cent bovine serum albumen).

Fig. 9

shows a rapid loss of activity when PFK was diluted 1:9 with buffer.
Loss of activity was slower at lower dilutions, but activity was lost
in all samples tested.
In other experiments, where little dilution of PFK occurred in
the desalting step, little or no PFK activity was lost for 3 hrs (data
not shown).

Therefore, further experiments using desalted crude

extract were done with care to avoid dilution of the crude extract
during the desalting step, and desalted extracts were used within 3
hrs without further dilution.
Stability of the resuspended 104,000 x g pellet.

PFK activity of

the 104,000 x g pellet was rapidly lost when it was resuspended in
0.03 M potassium fluoride, 0.2 mM EDTA, but activity could be recovered
by treatment of the resuspended pellet with 5.0 mM MgATP (Fig. 10).
PFK activity could be retained if the resuspending buffer contained
5.0 mM ATP (see Table II), or if the pellet was resuspended in 0.1 M
tris phosphate, pH 8.0, with or without 5.0 mM ATP.

When the
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FIG. 9.

Effect of dilution on stability of PFK activity in desalted

crude muscle extract.

Desalting was done on a 1.5 x 30 cm Sephadex

G-25 column which had been previously equilibrated with 0.1 M potassium
phosphate, pH 8.0, 1.0 mM EDTA, 5.0 mM 2-mercaptoethanol at 0 - 4°C.
The protein fractions were pooled and diluted with 0.1 M tris
phosphate, pH 8.0, 0.2 mM EDTA, 5.0 mM 2-mercaptoethanol, 0.1 per cent
bovine serum albumen as follows:
(•) 1:4, and ( □ ) 1:9.

(o) no dilution, (x) 1:1 (v/v),

Diluted samples were tested for activity,

using the fructose 1,6-bisphosphate-coupled assay at pH 7.8.
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FIG. 10.

PFK activity of the 104,000 x g pellet when resuspended

in 0.03 M potassium fluoride, 1.0 mM EDTA.

Samples were assayed

with (o) or without (x) activation (MgATP) prior to assay.
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TABLE II
STABILITY OF PFK ACTIVITY IN RESUSPENDED 104,000 X G PELLET
IN VARIOUS BUFFER SYSTEMS WITH OR WITHOUT MgATP ACTIVATION

Resuspension buffer*
1.

Activation PFK**

0.03 M potassium fluoride, 1.0 mM EDTA, 5.0
mM 2-mercaptoethanol (pH 5.7)

2.

No. 1, but with 0.1 per cent bovine

no

50

yes

100

no

15

serum albumen (pH 5.5)
3.

No. 1, but with 5.0 mM MgATP (pH 6.1)

no

100

4.

No. 1, but with pH adjustment to 8.5

no

5

yes

5

(pH 7.5 after 10 hrs)
5.

No. 1, but with 1.0 mM fructose 6-phosphate (pH 6.0)

6.

No. 1, but with 0.5 mM MgATP (pH 6.1)

no
no

50
50

7.

Original supematent (pH 6.3)

no

100

8.

Original supematent, made protein free by

no

50

no

100

ultrafiltration (pH 6.3)
9.

0.2 M imidazole chloride, pH 7.3, 5.0 mM ATP

10.

0.2 M tris phosphate, pH 8.0, 5.0 nM ATP

no

100

11.

0.2 M tris phosphate, pH 8.0

no

100

*

pH of resuspended pellet is in parentheses

** PFK activity after 24 hrs of incubation at 0 - 4°C is expressed
relative to activity just after resuspension.

resuspended pellet (in 0.03 M potassium fluoride, 0.2 mM EDTA) was
adjusted to pH 8.5, activity was lost, and could not be recovered by
treatment with 5.0 mM ATP.

PFK activity was lost when the pellet was

resuspended in a protein-containing buffer (0.03 M potassium fluoride,
0.2 mM EDTA, 0.1 per cent bovine serum albumen), as well as when it
was resuspended in the original supernatent which had been made
protein free by ultrafiltration (Amicon, PM-10 membrane).
Partial purification of rat muscle PFK.

Table III gives a

summary of the purification procedure, and Fig. 11 shows the chroma
tography of the resuspended 104,000 x g pellet on Reactive Blue 2Agarose.

The centrifugation of the crude muscle extract at 104,000

x g precipitated most of the PFK, since little activity could be
detected in the supematent (not shown), and centrifugation for a
longer period of time, or at higher speeds gave no further recovery
of activity in the pellet.

Chromatography on Reactive Blue 2-Agarose

resulted in further purification of PFK, since little of the protein
in the resuspended 104,000 x g pellet adhered to the Reactive Blue
2-Agarose (Fig. 11).

The PFK activity, bound to the Reactive Blue

resin, was eluted using an ammonium sulfate gradient.
Sodium dodecyl sulfate polyacrylamide gel electrophoresis of the
purification fractions showed an enrichment of the higher molecular
weight proteins by the 104,000 x g centrifugation step (Fig. 12).
Chromatography of the resuspended 104,000 x g pellet on Reactive Blue
2-Agarose resulted in a preparation which had one major, and two minor,
bands on polyacrylamide gels.

The major band was Identified as PFK,

by co-migration with rabbit skeletal muscle PFK (Sigma), and the lower
and higher molecular weight contaminants were identified as pyruvate

TABLE III
PARTIAL PURIFICATION OF RAT SKELETAL MUSCLE PFK
Fraction

volume units/ml total units recovery protein total protein specific activity fold
(ml)
(per cent) (mg/ml)
(mg)
units/mg protein purification

Crude extract

156

18.9

2953

100

8.0

1248

2.4

1.0

14 113.1

1561

53

18.0

248

6.3

2^6

983

33

1.2

18

54.6

22.8

104,000 x g
pellet
Reactive Blue
2-Agarose

15

65.5

FIG. 11.

Chromatography of the resuspended 104,000 x g pellet on

Reactive Blue 2-Agarose.

The resuspended pellet, containing 0.25 g

of protein, was applied to a 1.5 x 18 cm column which had been
previously equilibrated with 0.1 M tris phosphate, pH 8.0, 0.2 mM
EDTA.

The column was washed with 160 ml of buffer, then the PFK

activity was eluted with a non-linear gradient of ammonium sulfate
(0.0 - 1.25 M).
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FIG. 12.

Sodium dodecyl sulfate polyacrylamide gel electrophoresis

of PFK purification fractions.

Protein (30 - 80 yg) was layered

under the reservoir buffer, then gels were run at constant current
(5 - 8 ma per gel).

Staining was with Coumassie blue.
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AO
kinase and phosphorylase b, respectively, by co-migration with commercial
preparations of these enzymes (Sigma).

The purified PFK preparation

had pyruvate kinase activity (6 per cent of the PFK activity) and
phosphorylase activity (1 per cent).
PFK activity could not be eluted from the Reactive Blue 2-Agarose
when the eluant was 1.0 mM fructose 1,6-bisphosphate, 0.1 M tris
phosphate, pH 8.0, 0.2 mM EDTA; or 0.5 M tris phosphate, pH 8.0,
0.2 mM EDTA.

PFK activity could be eluted using a 0.0 - 5.0 mM ATP

gradient, but this procedure increased the contamination of the final
preparation with phosphorylase b.

AMP could also be used to elute

PFK activity from Reactive Blue 2-Agarose, but afforded no improvement
over ammonium sulfate.
Other attempts to increase purification of rat muscle PFK.
The following treatments of crude muscle extracts were unsuccessful
in increasing the specific activity of crude PFK:

(a) 50°C

heat treatment for 3 min (extract reached 30°C), followed by rapid
cooling in ice;

(b) adjustment of the extract to pH 5.0 for 30 min

at 0 - 4°C, and

(c) addition of isopropanol (25 per cent of muscle

extract volume)

at 0°C.

above, extracts

were

After treatment of crude extract as described

centrifuged at 10,000 x g for 30 minand tested

for PFK activity.
In attempts to increase the specific activity of the 104,000 x
g pellet, the pellet was resuspended in 0.1 M tris phosphate, pH 8.0,
0.2 mM EDTA, 5.0 mM 2-mercaptoethanol; (b) buffer "a" containing 5.0
mM ATP; or (c) buffer "a" containing 5.0 mM ATP and 8.0 mM citrate,
and centrifuged at 104,000 x g at 0 - 4°C for 2 hrs.
did not increase the purification of rat muscle PFK.

These treatments
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Following the Reactive Blue 2-Agarose step, chromatography of the
partially purified PFK on hydroxylapatite eliminated one of the
contaminating proteins from the partially purified PFK preparation,
but a loss (greater than 80 per cent) of PFK activity occurred.
DEAE-cellulose chromatography was also tried, but recoveries and
specific activities of PFK were less favorable than with Reactive
Blue 2-Agarose.
pH optimum of rat muscle PFK.

The activity of partially purified

rat muscle PFK was measured at various pH values, using both the ADPcoupled, and the fructose 1,6-bisphosphate assay systems, and identical
curves were obtained for the two assay, systems (Fig. 13).

The activity

of partially purified rat muscle PFK had a broad optimum at pH 7.8 to
pH 8.2, and PFK activity dropped off at pH values less than 7.5 or
greater than 8.5.

In the construction of the PFK pH curves, the

amount of auxilliary enzymes used in the assay was increased until
no further increase in PFK activity was apparent, particularly at pH
values where the activity of the auxilliary enzymes was low (see
below).
Since the measured activity of PFK at various pH values was
dependent, in part, on the activity of the particular auxilliary
enzymes employed in the assay, the pH curves of the auxilliary enzymes
were also constructed (Fig. 14 for the ADP-coupled assay enzymes and
Fig. 15 for the enzymes from the fructose 1,6-bisphosphate-coupled
system).
Kinetic analysis of partially purified rat muscle PFK.

Figs. 16

and 17 give the ATP and fructose 6-phosphate saturation curves,
respectively, for partially purified PFK when assayed at pH 7.8.

When

FIG. 13.

Sensitivity of partially purified PFK to pH, using

imidazole chloride (o) or tris chloride (x) as buffer.

Results

obtained with the fructose 1,6-bisphosphate coupled- and the ADPcoupled assay systems were identical.

PFK and auxilliary enzymes

were dialyzed (0.1 M tris phosphate, pH 8.0, 0.2 mM EDTA, 5.0 mM
2-mercaptoethanol) prior to use.
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FIG. 14.

Sensitivity of the auxilliary enzymes of the ADP-

coupled PFK to pH.

The enzymes were (A) pyruvate kinase, and (B)

lactate dehydrogenase, and the buffers were (o) Imidazole chloride
or (x) tris chloride.

All enzymes were dialyzed (0.1 M tris

phosphate, pH 8.0, 0.2 mM EDTA, 5.0 mM 2-mercaptoethanol) prior to
use.
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FIG. 15.

Sensitivity of the auxilliary enzymes of the fructose

1,6-bisphosphate-coupled assay to pH.

The enzymes were (A) fructose

bisphosphate aldolase, and (B) glycerol 3-phosphate dehydrogenase, and
the buffers were (o) imidazole chloride or (x) tris chloride.

All

enzymes were dialyzed (0.1 M tris phosphate, pH 8.0, 0.2 mM EDTA,
5.0 mM 2-mercaptoethanol) prior to use.
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FIG. 16.

Velocity of partially purified PFK at increasing

concentrations of ATP and pH 7.8.

The Michaelis constant + S.E.M.

for ATP, determined from these data, was 0.17 + 0.04 mM.

The fructose

1,6-bisphosphate-coupled assay was used in these determination,
and the fructose 6-phosphate concentration was 0.5 mM.
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FIG. 17.

Velocity of partially purified PFK at increasing

concentrations of fructose 6-phosphate (pH 7.8).

The Michaelis

constant + S.E.M. for fructose 6-phosphate, determined from these
data, was 0.11 + 0.02 mM.

The fructose 1,6-bisphosphate-coupled

assay was used in these measurements, and ATP was 0.5 mM.
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fructose 6-phosphate concentration was 0.5 mM, the Michaelis constant
for ATP (+ S.E.M.) was 0.17 + 0.04 mM (determined from a regression
analysis of the double reciprocal plot of the data).

The Km for

fructose 6-phosphate (ATP concentration = 0.5 mM) was 0.11 + 0.02 mM.
At pH 7.2, the partially purified enzyme showed sigmoidal
behavior to fructose 6-phosphate (Fig. 18), with an apparent Km
of 0.25 mM (determined by the substrate concentration where enzyme
velocity was half maximal).

A Hill number of 2.4 was calculated for

the partially purified enzyme, as determined from a plot of In S
versus In (Vmax-v)/v, where S=substrate concentration, Vmax=maximal
velocity, and v=velocity.

(See below for results on Km for ATP.)

Comparison of PFK activity in crude muscle extracts from normal
and diabetic animals.

Crude muscle extracts were prepared from muscle

of normal and diabetic rats, and the specific activity was measured
without prior dialysis of the crude extracts.

Table IV shows that the

specific activity of PFK in extracts from muscle of diabetic animals
was lower than that from normal animals.

The difference in PFK

activity persisted when tested under conditions which do not subject
PFK to allosteric control- (pH 7.8, p < 0 . 0 1 by paired t-test), or which
allow allosteric control of the enzyme (pH 6.7, p<0.05).
Comparison of specific activities of several enzymes of glucose
metabolism in muscle extracts from normal and diabetic animals.

Crude

extracts were dialyzed, and measured for specific activity of
phosphoglucomutase, glucosephosphate isomerase, PFK, fructose bisphosphate aldolase, pyruvate kinase, and fructose bisphosphatase.
specific activities of PFK, aldolase, and pyruvate kinase were
decreased in muscle extracts from diabetic rats (Figs. 19 and 20),

The
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FIG. 18.

Velocity of partially purified PFK at increasing

concentrations of fructose 6-phosphate (pH 7.2).
was 0.26 mM and the Hill number was 2.4.

The Michaelis constant

The ADP-coupled assay was

used in these determinations, and ATP was 0.5 mM.
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TABLE IV
SPECIFIC ACTIVITY OF PFK IN CRUDE EXTRACTS PREPARED FROM
SKELETAL MUSCLE OF NORMAL AND DIABETIC RATS
Values are means + S.E.M., with the number of pairs of animals in
parentheses.
Group

Normal

— PFK Specific activity—

Blood glucose

Body weight

non-allosteric allosteric

(mg/100 ml)

(g)

conditions

conditions

(17)

(8)

2.08 + 0.05
*

Diabetic

1.68 + 0.08

1.18 + 0.12

(17)
102 +

(17)
3

245 +

**

1.00 + 0.10

403 + 11 (m)

450 + 12

285 + 14 (m)
205 +

*statistically different, p <0.01 by paired t-test
**statistically different, p <0.05 by paired t-test

6 (f)

6 (f)

FIG. 19.

Specific activity + S.E.M. of enzymes in crude extracts

prepared from muscle of normal and diabetic animals.

The enzymes

were (1) phosphoglucomutase, (2) glucosephosphate isomerase, (3) PFK,
(4) fructose bisphosphate aldolase, and (5) pyruvate kinase.
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FIG. 20.

Specific activity + S.E.M. of several enzymes of glucose

metabolism in dialyzed crude extracts from muscle of diabetic rats,
expressed as a per cent of the activity from normal animals.

The

enzymes were (1) phosphoglucomutase, (2) glucosephosphate isomerase,
(3) PFK, (4) fructose bisphosphate aldolase, and (5) pyruvate kinase.
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whereas specific activities of phosphoglucomutase and glucosepho sphate
isomerase were equal in crude extracts from the two groups.

No

fructose bisphosphatase activity could be detected in any of the crude
muscle extracts under the conditions of this experiment (data not
shown).
Measurement of metabolites In muscle of normal and diabetic rats.
The levels of fructose 1,6-bisphosphate and glucose 1,6-bisphosphate
were decreased in extracts prepared from quick-frozen muscle from
diabetic rats (Table V).

On the other hand, the levels of citrate,

a potent inhibitor of PFK, were elevated in the muscle of diabetic
animals.

The levels of fructose 6-phosphate, glucose 6-phosphate, ATP,

ADP, and AMP were equal in muscle extracts from the two groups.
nuclear magnetic spectroscopy of extracts from quick-frozen
muscle from normal and diabetic rats.

The
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P spectra of extracts

from normal and diabetic rats (spectra not shown) indicated no
observable differences in phosphorylated metabolites, except in the
monophosphate ester region (4.7 - 5.3 ppm).

The position of the

resonances which differed between the two spectra coincided with the
position for fructose 1,6-bisphosphate, as shown by the addition of
this compound to the extract.

The most prominent resonance in each

spectrum was from creatine phosphate, followed by that of ATP.
observed resonances were:

The

4.7 - 5.3 ppm, sugar phosphates; 3.7 ppm,

inorganic phosphate; 0.0 ppm, phosphoric acid (external reference);
-2.2 ppm, creatine phosphate; -4.3 and -4.5 ppm, y-phosphate of ATP;
-4.7 and -5.0, 6-phosphate of ADP; -9.3 and -9.6, a-phosphate of ADP;
-9.9 and -10.1, a-phosphate of ATP; and -19.8, -20.0, -20.2, 6phosphate of ATP.
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TABLE V
LEVELS OF PFK MODULATORS IN MUSCLE
OF NORMAL AND DIABETIC ANIMALS
Values are means + S.E.M., with number of pairs of animals in
parentheses

— pinole per g of muscle
normal
+ 0.10

glucose 6-phosphate (7)

1.77

glucose 1,6-bisphosphate

0.020 + 0.004

diabetic
1.84

+ 0.33

P value
(paired t-test)
p > 0.05

0.007 + 0.002

p < 0.01

(15)
fructose 6-phosphate (7)

0.22

+ 0.01

0.24

+ 0.04

p > 0.05

fructose 1,6-bisphosphate

0.61

+ 0.10

0.31

+ 0.04

p < 0.05

citrate (15)

0.21

+ 0.01

0.26

+ 0.02

p < 0.05

ATP (15)

4.26

+ 0.48

5.59

+ 0.16

p > 0.05

ADP (12)

0.46

+ 0.04

0.73

+ 0.01

p > 0.05

AMP (12)

0.07

+ 0.01

0.07

+ 0.01

p > 0.05

(7)
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Sensitivity of partially purified PFK from normal and diabetic
rats to inhibition by ATP.

Fig. 21 shows

identical behavior of

partially purified PFK from normal and diabetic rats to ATP at pH 7.2.
The Michaelis constants for ATP (+ S.E.M., calculated from a regression
analysis of a double reciprocal plot of the enzyme velocities at ATP
concentrations less than 0.2 mM) were within experimental error
(0.32 + 0.09.mM for PFK from muscle of normal animals, and 0.41 + 0.13
mM for PFK from diabetic animals).

Fructose 6-phosphate was 0.5 mM in

these experiments.
Effect of insulin treatment of PFK activity in extracts from
muscle of diabetic rats.

Streptozotocin diabetic rats were given a

daily injection (intraperitoneal) of 10 units of regular insulin
(Iletin-40, Eli Lilly) or vehicle (0.8 per cent saline) for 5 days.
Three hrs after the final injection, the rats were sacrificed* and
extracts of the muscle were prepared as described in METHODS.

Table VI

shows a significant increase in PFK specific activity in crude
extracts from the insulin-treated rats (2.52 + 0.10 units/mg of protein,
mean + S.E.M., for insulin-treated animals versus 1.99 + 0.08 units/
mg for saline-treated rats).
Insulin treatment of muscle homogenates did not result
in increased PFK activity.

Incubation of homogenates with up to 16

units of insulin per 10 ml of homogenate followed by centrifugation
resulted in no change in PFK specific activity in the crude extract
(Table VII).

FIG. 21.

Sensitivity of partially purified PFK from muscle of

normal and diabetic rats to concentration of ATP (pH 7.2).

Data are

expressed relative to the enzyme activity at pH 7.8, when ATP and
fructose 6-phosphate concentrations were 0.5 mM and 1.0 mM,
respectively.

The Michaelis constants for ATP for the enzyme from

normal and diabetic rats (+ S.E.M.) were 0.32 + 0.09 mM and 0.41 +
0.13 mM, respectively (determined from regression analyses of
double reciprocal plots of the data at concentration of ATP less
than 0.2 mM).

The ADP-coupled assay was used in these measurements,

and fructose 6-phosphate was 0.5 mM.
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TABLE VI
PFK ACTIVITY IN CRUDE MUSCLE EXTRACTS FROM STREPTOZOTOCIN
DIABETIC RATS WITH OR WITHOUT INSULIN TREATMENT
PFK activity was measured by the ADP-coupled assay at pH 7.8

Treatment

Mean + S . E . M . -----------PFK specific activity
units/mg protein

blood glucose
mg/100 ml

Insulin (8 rats)

2.52+0.10

7 2 + 8

Vehicle (8 rats)

1.99+0.08

467+19

*

at time of sacrifice

** significantly different by student's t-test at p<0.001

TABLE VII
EFFECT OF IN VITRO INSULIN TREATMENT ON PFK ACTIVITY
IN HOMOGENATES OF SKELETAL MUSCLE OF DIABETIC RATS

pH of assay

units of insulin added

PFK Specific activity

to 10 mlof homogenate

(units/mg protein)

7.8

•

6.7*

0

1.51

4

1.45

8

1.45

16

1.54

0

1.61

4

1.54

8

1.64

*The amount of crude extract used in the assay at pH 6.7 was twice the
amount used at pH 7.8

DISCUSSION
Before a comparison of PFK activity in skeletal muscle of normal
and diabetic rats could be made, it was necessary to investigate the
properties of PFK from skeletal muscle of the rat.

Specifically, a

procedure was needed to stabilize PFK activity in crude extracts of
muscle, and throughout the purification scheme.
This report shows that PFK in crude muscle extracts could be
stabilized by a potassium fluoride, EDTA extraction buffer.

Potassium

fluoride did not stabilize PFK directly, since its inclusion in
dialysis buffer did not stabilize PFK activity (Table I), nor did
potassium fluoride stabilize the resuspended 104,000 x g pellet (Fig.
10).

EDTA varied in concentration in the various buffer systems, and

its concentration did not appear to be crucial.
Ling et al. (61) were the first to use potassium fluoride to
stabilize PFK in muscle extracts.

The fluoride anion has been used in

purification schemes by other laboratories (58,74), but the precise
mechanism for the stabilization of PFK activity by potassium fluoride
has not been determined, nor has the means of activation of PFK by
MgATP.
A possible explanation for the stabilization of PFK by potassium
fluoride is its glycolysis-inhibiting property.

By inhibition of

glycolysis at the enolase (E.C. 4.2.1.11) step, potassium fluoride
would slow the catabolism of PFK-stabilizing hexose phosphates.
Alternatively, potassium fluoride is known to inhibit phosphoprotein
58
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phosphatase (E.C. 3.1.3.2) (76), and thus could be preserving
a phosphorylated form of PFK or PFK-actlvatlng component.
Searches for a phosporylation-dephosphorylation control mechanism
of PFK activity have not been successful, however (34,62,77).

Fluoride

anion is also known to inhibit muscle ATPase (E.C. 3.6.1.3) (78),
adenylate deaminase (E.C. 3.5.4.6) (79), and adenylate kinase (E.C.
2.7.4.3) (80), and inhibition of these enzymes could affect
preservation of PFK activity.
Another possible explanation is the activating effect of cyclic
AMP on PFK, and the known adenylate cyclase (E.C. 4.6.1.1)-activating
effect of potassium fluoride (81).
cyclase

However, the substrate of adenylate

(ATP) is low in concentration in extracts prepared from

excised muscle (measured as <0.04 mM, data not shown), and therefore,
production of cyclic AMP may not account for the ability of potassium
fluoride to stabilize PFK activity over long periods of time (1 week).
The mechanism for preservation of PFK activity by potassium fluoride,
therefore, remains elucive.
When potassium fluoride was not included in the extraction buffer,
PFK activity could be stabilized by high pH (Fig. 5) or by treatment
with 5.0 mM MgATP (Figs. 4 and 6).

The tetrameric (active) form of

purified rabbit muscle PFK has been shown to be stabilized by high
pH (8.0), ATP, fructose 6-phosphate, or fructose 1,6-bisphosphate (24,
28,29).

In these experiments, therefore, treatment of muscle extracts

with high pH, ATP, or potassium fluoride may work by preserving the
active (tetrameric) form of PFK.

The data in Table II are in agreement

with this explanation, in that the PFK activity in the resuspended
104,000 x g pellet was stable if the resuspension medium was high pH
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(8.0) phosphate buffer, or if the medium contained 5.0 mM ATP.
Stabilization of PFK activity appeared to be complex, since PFK
activity was not stable when the 104,000 x g pellet was resuspended
in potassium fluoride, EDTA buffer, and adjusted to high pH (8.5,
Table II), nor was PFK stable in crude muscle extracts when dialyzed
against buffer containing hexose phosphate or ATP, or a buffer of
high pH (8.0, Table I).

In addition, PFK activity was not stable

when crude muscle extract was diluted in buffer containing high
levels of ATP.

These observations suggest that there may be some PFK

stabilizing factor present in crude muscle extract

which is generated

from ATP and preserved by potassium fluoride.
Moreover, maintainance of PFK activity in crude muscle extracts
may involve a large molecular weight component, since resuspension of
the 104,000 x g pellet In its own deproteinated supematent (supernatent had been subjected to ultrafiltration to remove high molecular
weight components) resulted in PFK activity loss (Table II).

Resuspen-

tion of the pellet in its untreated supematent resulted in retention
of activity, indicating that the loss of PFK activity (above) was not
due to the high speed centrifugation.
Based on these experiments, the following procedures were used
for further work:

1)

Crude muscle extracts were prepared using 0.03 M

potassium fluoride, 1.0 mM EDTA, as this formula stabilized PFK
activity in crude muscle extracts,

2)

the 104,000 x g pellets were

resuspended in 0.1 M tris phosphate, pH 8.0, 0.2 mM EDTA, and this buffer
buffer was used for dilution of crude muscle extracts; 3)

desalted

crude muscle extracts were used within 3 hrs of desalting, as the PFK
activity was stable in this time period; and 4)

dialysis of crude
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muscle extracts was avoided, wherever possible.
In contrast to the many procedures available for purification
of rabbit muscle PFK (61,74,82), few purification schemes have been
worked out for rat muscle PFK.

Tornheim and Lowenstein (15) reported

a purification procedure for rat muscle PFK, claiming a 52-fold
purification (23 fold is reported here) and a 75 per cent recovery
(33 per cent reported here).

However, these authors did not include

potassium fluoride in their extracting buffer, and in a later step,
incubated the preparation with 5.0 mM ATP.

Their recoveries and yields

were high, in that these calculations would have been based on
inactivated PFK in the crude extract, and ATP-reactivated PFK
in the final preparation.

The final preparation was contaminated with

several enzymes and therefore was not as clean as the PFK preparation
reported here.

The PFK preparation described in this report gave PFK

which was sufficiently clean to be used for comparison of kinetic
properties of PFK from normal and diabetic rats.
This investigation revealed a significant decrease in PFK activity
in the muscle of diabetic rats.
types of experiments:

1)

This finding is supported by two

a decrease in PFK activity in extracts

prepared from muscle of diabetic animals (Table IV); and 2)

a

decrease in the fructose 1,6-bisphosphate/fructose 6-phosphate ratio in
extracts prepared from fast-frozen muscle of diabetic rats (Table V) .
The decreased PFK activity in crude muscle extracts from diabetic
animals could be reversed by insulin treatment (Table VI).

Taunton

et al. (43) also reported increased PFK activity in muscle extracts
prepared from insulin-treated animals, as did Ozand and Narahara (42).
These earlier studies suggested a short term effect of insulin, since
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the effects seen by these workers were immediate.

In the experiments

reported here, the decreased PFK activity in the muscle of diabetic
animals was not due to allosteric control, because PFK activity was
measured under non-*allosteric, as well as allosteric, conditions.
These results are in agreement with those of Ianuzzo and Armstrong
(41), but are in contrast to those of Hansen and Veneziale (40).
Possible explanations for decreased PFK activity in diabetic
rats include a decreased synthesis, or increased degradation of PFK,
or a covalent (inactivating) modification of PFK.

Ah increase in the

rate of degradation of rat liver PFK from diabetic animals was
observed by Dunaway et al.) (49), but a similar increase in PFK
degradation in muscle of diabetic animals has not been demonstrated,
nor has a decrease in synthesis of PFK.

The results in Figs. 19 and

20 suggest an attractive theory for an insulin-mediated increase in
glycolytic enzymes.

Figs. 19 and 20 show that three enzymes of glucose

metabolism were decreased in activity in the muscle of diabetic
animals, and two enzymes were not decreased.

The three enzymes which

were decreased in activity (PFK, aldolase, and pyruvate kinase) were
unique to glycolysis, whereas the two enzymes which were not decreased
(phosphoglucomutase and glucosephosphate isomerase) were not unique to
glycolysis.

Insulin may increase the concentration of an

inducer for the de novo synthesis of the enzymes of glycolysis,
and thereby mediate the levels of glycolytic enzymes concurrently.
An alternative explanation for the decrease in PFK activity in
the muscle of diabetic animals is a covalent modification of PFK.

If

a covalent modification was involved in the regulation of PFK in the
muscle of diabetic animals, an alteration in kinetic behavior might
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be apparent, as was seen for livers of genetically diabetic mice by
Hosey 6t_al. (51).

However, partially purified PFK from muscle of

normal and diabetic rats showed equal sensitivity to inhibition by
ATP, and had statistically identical Michaelis constants for ATP
(Fig. 21).

While this kinetic analysis suggests that a covalent

modification does not explain the decreased PFK activity in the muscle
of diabetic animals shown in Table IV, a covalent modification of
PFK cannot be ruled out at this time, since future work may reveal a
covalent change not detected by the conditions of these experiments.
The levels of allosteric effectors of PFK in vivo could strongly
affect muscle PFK activity, based on the kinetic analysis of partially
purified PFK.

For example, the Michaelis constant for ATP was

determined to be 0.3 - 0.4 mM when fructose 6-phosphate was 0.5 mM,
and the pH was 7.2 (Fig. 21).

The measured in vivo concentration

of fructose 6-phosphate was close to the level used in this kinetic
analysis (0.2 mM, Table V), and the in vivo concentration of ATP was
4 - 5 mM.

Under these conditions, PFK would be strongly inhibited by

ATP, and dependent upon the presence of positive effectors of PFK for
activity.
This report shows decreased levels of two positive effectors of
PFK in the muscle of diabetic rats, and increased levels of one
inhibitor.

Fructose 1,6-bisphosphate and glucose 1,6-bisphosphate

(PFK activators) were decreased in concentration in the muscle of
diabetic animals.

Decreased levels of fructose 1,6-bisphosphate were

also observed for heart muscle (36,37,39) from diabetic rats.

A

comparison of the levels of glucose 1,6-bisphosphate in muscle of normal
and diabetic animals has not been previously reported.

Muscle of

diabetic rats had increased levels of citrate (PFK inhibitor), in
agreement with the results of Parmeggiani and Bowman (38).

Increased

levels of citrate have also been demonstrated in the heart and liver
of diabetic animals (38).

ATP, ADP, and AMP are known effectors of

PFK, but no differences in the levels of these three modulators
were found in the muscle of normal and diabetic animals, in agreement
with the results of Regen et^ al. (39) and Newsholme and Randle (37) for
heart muscle.

No unexpected phosphorylated metabolites were detected

in the muscle of diabetic animals by
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P

nuclear magnetic resonance

spectroscopy, in contrast to the findings of Burt et al. (83) for
dystrophic muscle.
This investigation has shown decreased activity of PFK in muscle
of diabetic rats, due to 1)

a decrease in the extractable activity of

PFK, reversible by insulin treatment; and 2)
in allosteric modulators of PFK.

an unfavorable change

Moreover, the levels of glucose

6-phosphate and fructose 6-phosphate were equal in the muscle of normal
and diabetic rats (Table V), indicating glucose transport was not
limiting in the metabolism of glucose in muscle, thus emphasizing the
importance of this work.

CHAPTER II.

GAS CHROMATOGRAPHIC PROCEDURE FOR THE ANALYSIS OF GLUCOSE
ANOMERS IN THE BLOOD OF NORMAL AND DIABETIC RATS
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INTRODUCTION
Glucose exists in at least two anomeric forms, and consequently
glucose receptors and glucose transport systems have been found that
are specific for either the a or the 6 anomer of glucose.

The

OH
a

3

(36 - 39%)

(61 - 64%)

relative concentrations of glucose anomers in the blood, as well as
the total glucose concentration, could affect rates of
glucose utilization.

Enzymes using glucose as substrate have not

shown specificity for either anomer of glucose; however, enzymes
using glucose 6-phosphate as substrate show anomeric specificity, and
therefore the relative concentrations of a and 3 glucose could affect
enzymatic rates indirectly.
Mutarotase (E.C. 5.1.3.3, aldose 1-epimerase) is an enzyme
which catalyzes the equilibration of glucose anomers, and is high
in activity in liver, kidney, and intestine.

Transport processes and

enzymes which preferentially utilize one glucose anomer over the
other could tend to enrich the blood in one anomer, whereas mutarotase
would be expected to equilibrate the relative concentrations of anomers.
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Effect of g and B glucose on insulin and glucagon secretion.
Insulin is secreted by the pancreas in response to a rise in glucose
concentration in the blood.

Recently, it has been determined that

the a anomer of glucose is the actual secregogue responsible for the
insulin response.

Rossini et al. (84) infused a or 8 glucose into

live, anesthetized rats which had been fasted for 24 hr, and found
that more insulin was secreted into the blood when a-glucose was the
anomer used.

Similarly, more insulin was secreted by perfused rat

pancreas when a-, rather than 8-glucose was included in the perfusion
medium (84).

The specificity of the pancreas for the a anomer was

most pronounced after 1 min of infusion, probably due to the rapid
mutarotation of glucose at physiological temperature during longer
infusion periods.

Niki et al. (85) also demonstrated that more

insulin was secreted from rat pancreas when perfused with the a-,
rather than the 8"» anomer of glucose, and Idahl et al. (86) showed
that more insulin was released when a-glucose was perfused through
islets from mice.
McDaniel et al. (87) isolated rat islets by the collagenase
technique, and perfused them with solutions containing a- or 8-glucose.
More insulin was released from the islets when the a anomer was used,
at a concentration of 150 mg per 100 ml.

At higher concentrations,

the differences between the results of experiments using a- or 8“
glucose were not distinct; however this may have been due to
spontaneous mutarotation of the glucose anomers.

Consistent with the

effects of glucose anomers on pancreas cells from rats and mice,
Hill (88) demonstrated that when fasted dogs were infused intravenously
with a or 8 glucose, more insulin was released into the blood when
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a-glucose was the anomer used.
Glucagon is a hormone whose effects are generally antagonistic
to those of Insulin.

Glucagon Is secreted by the a cells of the

pancreas, and its secretion is inhibited by serum glucose.

Rossini

et al. (84) reported more inhibition of glucagon secretion when aglucose, versus 6-glucose or equilibrated glucose, was perfused
through rat pancreas.

Grodsky et al. (89) also showed increased

insulin, and decreased glucagon secretion when a-glucose was perfused
through rat pancreas.

Thus, the specific effect of a-glucose was

shown to be the stimulation of the secretion of insulin, and the
inhibition of the secretion of glucagon.
Newton eit al. (90) compared the sensitivity to a- and 8-glucose
of pancreatic islets from lean mice to the sensitivity of islets
from their genetically obese litter mates.

Islets from lean mice

showed an expected increase in insulin secretion when perfused with
a-,

rather than 6-glucose.

On the other hand, islets from the obese

mice did not distinguish between glucose anomers, suggesting a defect
in the specificity of the glucose receptor in islets from the obese
mice.
The synthesis of proinsulin has been shown to be stimulated
specifically by the a anomer of glucose (91).

Isolated islets from

rats were perfused with equilibrated glucose for 60 min, then with
a- or 6-glucose for 3 - 5 min periods, followed by treatment with the
same anomer of glucose and radioactive leucine (5 min).

After

termination of the experiment with cold leucine, proinsulln and insulin
were isolated together by immunoprecipitation, and incorporation of
labeled leucine into newly synthesized insulin and proinsulin

was determined.

At glucose concentrations of 100 mg per 100 ml,

perfusion with the a anomer resulted In more synthesis of (pro)Insulin.
The Insulin secretory response of the pancreas to glucose Is
accompanied by accumulation of cyclic AMP In the Islets and efflux
of Inorganic phosphate from the 3 cells, and both of these responses
were more pronounced when the a anomer of glucose was used to perfuse
Islet cells (92,93).

When Isolated rat Islets were Incubated with a

phosphodiesterase inhibitor, radioactive ATP, and a- or 3-glucose,
higher levels of cyclic AMP could be extracted from the islets
when a glucose was the anomer used (150 mg per 100 ml) (92).

In

another study, isolated islets were prelabeled with radioactive
inorganic phosphate by a 90 min preincubation at 37°C, then perfused
with 90 mg per ml of a-glucose or equilibrated glucose.

In this

investigation, more phosphate was recovered from the medium when the
perfusion buffer contained a-glucose (93).
Treatment of animals with alloxan results in reduced insulin
secretion due to alloxan induced damage to the 3 cells (94).

The a

anomer of glucose was more effective than was 3-glucose in protecting
the pancreas from alloxan toxicity (85,87,95).

When isolated rat

islets were perfused with alloxan and with a- or 3-glucose, the islets
sustained less damage when a-glucose was the anomer used (87).

Niki

et al. (85) also showed better protection against alloxan toxicity in
isolated rat islets using the a anomer of glucose.

The 3 anomer of

glucose gave more protection than the control (no glucose); however
this could have been due to mutarotation of the 3-glucose during the
experiment.

Tomita and Kobayashi (95) demonstrated anomer specific
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protection against alloxan toxicity in a similar experimental design,
also showing better protection of the 3 cells by a-glucose.
Insulin mediated Changes in blood glucose anomers.
Madreiter et al. (96) reported an increase in the relative concentra
tion of the a anomer of glucose in blood following administration of
insulin to children.

However, a change in the anomeric composition

of blood glucose could not be demonstrated in normal or diabetic dogs
when given 0.4 to 0.5 units of insulin (intravenous) per kg of body
weight (88).

In both of these studies, initial glucose concentrations

were near equilibrium.
Specificity of glucose transport mechanisms for a- or 3-glucose.
pancreatic islets. When isolated islets were incubated at 37°C
3
with labeled (1- H) a- or 3-glucose, more radioactivity disappeared
from the medium when 3-glucose was the anomer used (97), indicating
specific uptake of the 3 anomer of glucose.

Idahl et al. (86)

3
incubated islets with equilibrated (5- H) glucose and unlabeled aor 3-glucose, and showed more dilution of

3
^ 0 in the cells when 3-

glucose was the anomer used, supporting preferential uptake and
metabolism of 3-glucose.

More glucose 6-phosphate was found in

intact islets after perfusion with 3-glucose than when perfused with
a-glucose (86), and since hexokinase was shown to phosphorylate
a- and 3-glucose at equal or nearly equal rates (98), this indicated
faster uptake of the 3 anomer.
In contrast to the above reports of specific transport of 3glucose in pancreatic islets, Idahl et al. (86) reported equal
counter transport of 3-0-methyl glucose in preloaded islets for
both glucose anomers.

In another experiment, islets were perfused

without glucose, then exposed to 108 mg per 100 ml of a- or B-glucose.
The resulting glucose 6-phosphate in islets was equal in concentration
for both glucose anomers (99).

A third experiment showed that equal

3
concentrations of

were generated from islets perfused with

3
a- or (3-glucose (5- H) (98).

Whether or not glucose transport is

anomer specific in pancreatic islets is uncertain.
Whereas the studies discussed above showed faster uptake of
the (3 anomer of glucose into pancreatic islets, or no specificity,
Malaisse at al. (100) showed faster metabolism of a-glucose in
pancreatic islets.

When intact islets from rats were incubated with

a- or (3-glucose for 5 min, lactate production was facilitated when
the a anomer was used.

In another experiment, islets were incubated

14
for 5 min with labeled ( C) equilibrated glucose and unlabeled a- or
B-glucose.

The radioactive carbon dioxide was more highly diluted

when the a anomer was used, supporting a a-glucose specific step
in either transport or metabolism (100).

These data suggest that the

glucose transport system for pancreatic cells may be specific for 8glucose, or non-specific, whereas the glycolytic pathway may have
a rate limiting step which is a-glucose specific.
brain.

Betz e£ al. (101) demonstrated more inhibition of

3
H-glucose transport in canine brain, perfused in situ with a-glucose,
indicating preferential transport of a-glucose by the blood-brain
glucose carrier.

In cerebral cortex slices, however, a lower Km

for glucose transport was found for the g anomer (10 mM) than for the
a anomer (16.3 mM), suggesting faster uptake of B-glucose (102).
Similarly, in synaptosomes, neurons, and glial cells, uptake of 8glucose was faster than was the uptake of a-glucose.

The different

anomeric preferences in these studies may have resulted from multiple
transport systems in the brain, since glucose must pass the capillary
vail as well as the plasma membranes of glia and neurons, each of
which could show different transport properties (103).

Okuda (102)

has suggested that the rate

limiting step in vivo may be the higher

Km step (3-glucose specific

at the glial cell membrane), with glucose

passing through the glial cell to reach the neuron.
kidney and intestine.

Glucose is reabsorbed in the proximal

tubule of the kidney by an active transport process.

Both anomers

of glucose were shown to be equally absorbed, as determined by a
study in which glucose anomers were infused into the jugular veins of
dogs and sampled in the renal veins (104).

The small intestine also

uses active transport as the major mechanism of glucose transport,
and the rates of absorption

of a-, 3-, and equilibrated glucose

were found to be equal (105) .
red blood cells.

Glucose enters the erythrocyte by facilitated

diffusion, and.red cells showed preferential uptake of the 3 anomer
of glucose (106).
ascites tumor cells.

Erlich ascites tumor cells contain an

active transport mechanism for glucose, and showed preferential
uptake of the 3 anomer of glucose (107).
retina.
retina.

Okuda et al. (108) studied uptake of glucose in rat

When incubated for 3 - 5 min in solutions of a- or 3~glucose

glucose uptake was higher when 3~glucose was the anomer used.
bacteria.

13
Using (1- C) labeled glucose and nuclear magnetic

resonance spectroscopy, Ugurbil et al. (109) showed faster
disappearance from the medium of 3-glucose for Escherichia coli
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cells.

In a separate study, Ishihara et al. (110) monitored oxygen

consumption of germinating spores, and observed that more oxygen
was consumed when spores were incubated with 0-glucose.

The

preferential utilization of 0-glucose by Bacillus subtilis and
Bacillus meeaterium spores was explained by the rapid production of
0-glucose specific dehydrogenase in sporulating cells.

Dormant

spores of JJ. meeaterium germinated when exposed to the 0, but not
the a anomer of glucose ( H I ) .
yeast.

It was shown as early as 1922 that a-glucose was utilized

faster than 0-glucose in the early stages of fermentation (112),
suggesting a difference in transport or metabolism for the two anomers.
More recently, Ehwald et al. (113) confirmed this finding for yeast,
using aerobic and anaerobic conditions.

The a anomer was also more

effective in inhibiting uptake of 2-deoxyglucose.

Since 2-deoxy-

glucose phosphorylation was inhibited equally by a- and 0-glucose,
the rate limiting step in glucose metabolism by yeast was suggested
to be a-glucose specific transport into the cell (113).
Anomeric specificity of enzymes which use glucose 6-phosphate
as substrate.
glucosephosphate isomerase.

Isomerization of glucose 6-phosphate

to fructose 6-phosphate, catalyzed by glucosephosphate isomerase, was
faster with the a anomer of glucose 6-phosphate, suggesting specificity
of glucosephosphate isomerase for a-glucose 6-phosphate (99,114).

In

addition, glucosephosphate isomerase was shown to catalyze the
anomerization of a-glucose 6-phosphate, but not 0-glucose 6-phosphate,
suggesting specific binding of a-glucose 6-phosphate to the enzyme
(114)•

Schray et al. (115) found that 6-glucose 6-phosphate was also
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used as substrate, but at a slower rate.

In the reverse direction,

a- and 3-glucose 6-phosphates were both products, but the a anomer was
produced 10 fold faster than was 3-glucose 6-phosphate (116).
glucose 6-phosphate dehydrogenase.

The initial enzyme of the

pentose monophosphate pathway was found to be specific for the 3
anomer of glucose 6-phosphate (100,114,117) .
phosphoglucomutase.

Phosphoglucomutase was shown to be specific

for a-glucose 6-phosphate, and a-glucose 1-phosphate was the product
of this reversible reaction (98).
Lack of anomeric spcificity for enzymes which use glucose as
substrate.
hexokinase.

Hexokinase (E.C. 2.7.1.1) has been reported to

catalyze phosphorylation of both anomers of glucose at similar
rates, and to have equal, or nearly equal, Michaelis constants for both
anomers of glucose (98,100,102,107,113,118,119).
glucokinase.

Glucokinase (E.C. 2.7.1.2) had no specificity for

either anomer of glucose, but acted on both anomers at equal rates
(118)•
mutarotase.

Mutarotase catalyzed the anomerization of both

anomers of glucose, and had equal Michaelis constants for a- and B~
glucose (120).

The Michaelis constants for both anomers of glucose

were approximately three orders of magnitude higher than the Km
values for hexokinase and glucose 6-phosphate dehydrogenase,
reflecting the high flux of glucose through organs with mutarotase
activity (121).
Function of mutarotase.

The precise function of mutarotase is

not known, but kinetic constants for mutarotase have been shown to

be similar in magnitude to those for glucose transport (122-127).
Therefore, a role in glucose transport has been suggested.

However,

Okuda et al. (128) have shown that the cellular location of mutarotase
is incompatable with a role in glucose transport, in that kidney
mutarotase was localized in the nucleii of epithelial cells of renal
tubules and glomeruli, and liver mutarotase was in the nuclei of
paranchymal cells.

In addition, it has been shown that tissues of

high glycolytic activity are low in mutarotase activity (129,130).

The

actual function of mutarotase may involve the maintainance of glucose
equilibrium.

Although spontaneous mutarotation of glucose at

physiological temperature was shown to be rapid ( t - ^ “

min)

(131), infusions of a- or g-glucose into the blood of dogs did not
reach equilibrium for more than 15 min when the blood was passed
through a heart-lung machine (ie. the blood was not passed through
organs of high mutarotase activity).

On the other hand, equilibrium

was reached in the blood of the intact dog within 5 min.

This

investigation suggested a role for mutarotase in the maintainance of
glucose equilibrium, as did another study which showed the liver
and kidney to be the most efficient organs for equilibration of
anomers of blood glucose (104,132).
Anomerization as a rate limiting step in metabolism.

It has

been suggested that mutarotation of glucose 6-phosphate would not
be a rate limiting step in vivo because of the fast mutarotation
of glucose 6-phosphate at physiological temperature ( t ^ ^ “ 1*5 sec)
(118).

Malaisse (100) showed in vitro, however, that at low glucose

concentration (11 yM), the rate of appearance of phosphorylated
fructose was faster with crglucose as substrate than with 6-glucose
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when glucose 6-phosphate was generated in situ.

The possibility

that anomerization of glucose 6-phosphate Is a rate limiting step
in vivo remains unresolved.
On the other hand, anomerization of non-phosphorylated glucose
at physiological temperature was slower (t^/2 ™

m ^n ) (131),

and the documentation of glucose anomer-specific transport processes
suggests that mutarotation of glucose could be rate limiting in vivo.
Physiological examples have not been demonstrated, however.
Methology used in the study of glucose anomers in biological
tissues.
polarimetry.

The earliest measurement of glucose anomers in

serum was done in 1925 by Lundsgaard, who utilized polarimetry (133).
Other analytical methods (below) have superseded polarimetry as
a means of measuring glucose anomers in biological fluids because of
the lack of specificity and the low transmission of light through
fluids of biological origin.
methods involving anomer-specific enzymes.

Enzyme assays have

afforded greater specificity in the study of glucose anomers.
Bacterial glucose oxidase (E.C. 1.1.3.4), specific for B-glucose,
has been used in the determination of the relative concentrations
of glucose anomers (134):
B-glucose +

0^

glucose oxidase— ^ gluconolactone +

Levels of enzyme were adjusted, such that the rate of anomerization
was slow compared to the oxidation of glucose, and the consumption
of

B-glucose could be monitored using an oxygen electrode (85,102,

121,134)» or by using a chromogen and peroxidase (E.C. 1.11.1.7)
(66,88,135,136).
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peroxidase

^2°2 + c^iromo8en

color change in response
to consumption of

The amount of total glucose was determined from the 3-glucose
concentration after achievement of equilibrium and the known
concentration of

and 3-glucose at equilibrium.

Glucose was

brought to equilibrium by the use of alkali (88), or by waiting for
completion of spontaneous mutarotation (24 hrs) (89,91).

An

alternative procedure was to use glucose oxidase £0 measure g-glucose,
then to add mutarotase to catalyze the anomerization of the remaining
a-glucose to g-glucose, thereby allowing quantitation of g-, and total
glucose (66,135).
Another enzymatic procedure utilized hexokinase and glucose 6phosphate dehydrogenase (96).

The sample was divided into two parts,

and one part was treated with glucose oxidase (specific for g-glucose) ,
followed by acid treatment to inactivate the glucose oxidase.

The

concentrations of total glucose (untreated sample) and a-glucose
(glucose oxidase-treated sample) were then quantitated, using
hexokinase and glucose 6-phosphate dehydrogenase.
Purpose of this investigation.

Because of the evidence for

anomeric specificity exhibited by glucose receptors, glucose transport
systems, and glucose 6-phosphate utilizing enzymes, it was of interest
to compare the anomeric composition of glucose in the blood of animals
with normal glucose metabolism with that of animals showing abnormal
glucose metabolism.

Hxis report describes a gas chromatographic

procedure for the accurate and precise determinations of the in vivo
composition of glucose anomers in blood, and gives data indicating
that the anomeric composition of glucose in normal and diabetic

rats remains close to the thermodynamic equilibrium in water, whether
the rats are fed or fasted, and whether they are treated with insulin
or not.

Small, but significant changes in the relative concentrations

of a- and 3-glucose anomers occurred upon administration of insulin
to normal rats, and are reported here.

METHODS
Polarlmetric determination of optical purity of Rlucose.
D-glucose (2.5 g of a- (ICN Inc.) or 6- (Pfanstiel Labs Inc.)) was
weighed into a 50 ml volumetric flask.

Water (20°G) was added to

the mark and the glucose was dissolved by vigorous shaking, after which
the solution was transferred to a 1 decimeter polarimetric cell
equipped with a waterbath (20°C).

Optical rotation readings were

taken in a Perkin Elmer 141 (digital readout) polarimeter at timed
intervals (a ) for 60 min, then again after 24 hr (a ).
L

A plot of

In (a - a ) versus time was made, and the initial reading was
c
determined by extrapolation.

The optical purity was calculated by

comparison of the t = 0 min values with literature values for
a-D-glucose (112°) and (J-D-glucose (18.7°) (137).
Derivatization of glucose-containing samples for gas
c hromatography.
(138) was used:

A modification of the procedure of Sweeley et_ al.
hexamethyldisilazane (Pierce Chemical Co.) was

mixed with trimethylchlorosilane (Pierce) in a 2/1 ratio (v/v) and
chilled in ice.

To a cold, capped vial containing dry glucose

(0.02 to 1.0 mg) was added by syringe, 0.2 ml of derivatlzing agent
and 0.2 ml of dimethylsulfoxide.

The mixture was shaken vigorously

for a few min, after which the two phases were allowed to separate,
and an aliquot of the upper phase, containing the derivatized glucose
was injected into the gas chromatograph.

If an emulsion formed, it

was broken by refrigeration of the samples.
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The use of dimethylsulf-

oxide

as solvent rather than the more conventional pyridine served

to solubilize the dry sugar for derivatization, and to concentrate
the derivatized sugar in the upper phase.

Less tailing occurred in

the gas chromatographic analysis when dimethylsulfoxide was used
than with pyridine since little dimethylsulfoxide was contained in
the injected sample (upper phase).
Gas chromatography of glucose containing samples.

Derivatized

samples (1 - 5 yl of upper layer) were injected onto a 1/8" x 6 ' column
(3 per cent SE-30 on Chromsorb W(HP), 80/100 mesh, Pierce) which
contained a glass sleeve in the injection port.

The gas chromatograph

(Hewlett Packard model 5840, equipped with a microprocessor and flame
ionization detector) was programmed from 165 to 175°C at 0.5°C/min.
The column was reconditioned between runs at 250°C for 5 min.

Unless

otherwise stated, the flow rate (nitrogen) through the column was
20 ml per min.
Preparation of 1,2,3,4,6-trimethylsily1-glucose.

Dry glucose

(500 mg of a- or 6“ » 2.8 mmol) was added slowly to a cold solution
of 2 ml of pyridine, 1 ml of trimethylchlorosilane, 2 ml of hexamethyldisilazane, and 3 ml of hexane in a 25 ml Erlenmeyer flask, and
stirred overnight at 3°C.

Saturated saline (10 ml) was added, and the

desired product was extracted with cold hexane (10 ml) three times.
The hexane layers were combined and washed with cold 1 mM hydrochloric
acid, saturated in saline until the wash layer was acidic by pH paper.
Hie hexane layers were dried (anhydrous sodium sulfate) and the
solvent was removed by evaporation under reduced pressure.

Ihe

derivatized a- and 6-glucose samples were mixed in varying ratios,
then diluted 1/1 (v/v) (carbon tetrachloride) for analysis by
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nuclear magnetic resonance spectroscopy, or 40 mg/25 ml (hexane) for
gas chromatography.
Induction of experimental diabetes in animals.

Sprague-Dawley

rats (150 - 250 g) were made diabetic by injection into the tail
vein of 40 - 50 mg alloxan (anhydrous basis) per kg of body weight
following a 48 hr fasting period, or by injection of 65 mg streptozotocin (Sigma) per kg.

All diabetic rats used in this experiment

showed non-fasting blood glucose levels greater than 250 mg per 100
ml of blood.
Collection of blood samples.

Blood was collected onto a piece

of parafilm by snipping 1 cm from the tail of each rat, and 50 yl
blood aliquots were quickly measured into previously prepared organic
solvent (below).
the tail.

Usually 3 samples were taken within 30 sec of cutting

All samples were taken between 8:00 and 9:30 AM, and were

cooled in dry ice immediately after collection.

For experiments where

anomeric composition of plasma was measured, the animals were
sacrificed by decapitation, and several ml of blood was collected
into a heparinized beaker at 0 - 4°C.

After centrifugation in a

Brinkman tabletop microcentrifuge, model 5412 at 3°C, plasma samples
were treated as for whole blood.
Preparation of blood samples.

Eppendorf centrifuge tubes (1.5

ml) containing 0.4 ml of chloroform/methanol (10/1, v/v) .and 20 yl
of 1 mg/ml mannitol in 0.8 per cent saline (internal standard) were
chilled in a salt/ice bath.

Fifty yl of blood was added, after which

the tube was capped, mixed by vortex mixer, and centrifuged in the
cold room (3°C) for 1 min.

The entire upper layer (methanol) was

transferred to a prechilled (dry ice/acetone) 3 ml vial, using an

Eppendorf pippette with prechilled (dry ice) tips.

After chilling

in dry ice/acetone, the vials were quickly transferred to prechilled
(dry ice) flasks, which were then attached to a lyophilization unit.
The dried samples were capped and derivatized immediately.
Determination of blood glucose.
gas chromatographic procedure.

The amount of glucose in blood

samples was determined using an internal standard (mannitol) by the
following equasion:
me elucose - (n>e mannitol)(peak area for a- and B-glucose)
(0.826)(peak area for mannitol)
The correction factor for mannitol (0.826) was determined from 10
samples containing known amounts of glucose and mannitol.
enzymatic procedure.

Restrained rats were warmed for a few min

with a heating mantle, then 1 cm of the tail was excised.

Heparinized

blood samples (20 yl) were measured into 100 yl of distilled water,
and were made protein free by a modification of the method of Somolygi
(65), as described under METHODS, CHAPTER I.

Glucose was measured

according to the method of Okuda et al. (66), using 0.1 per cent
glucose as a standard.

RESULTS
Optical purity of glucose samples.

Fig. 22 shows the change

in specific rotation with tine for a sample of each of a- and g-Dglucose.

Comparison of the extrapolated specific rotation at t ** 0

min with literature values for a- and g-glucose gave an optical
purity of 98.5 and 96.6 per cent for the preparations of

a- and g-D-

glucose used in this investigation, respectively (Table VIII).
Gas chromatography.

Fig. 23 gives a typical gas chromatographic

trace of a rat blood sample.

The a- and g-glucose peaks were the

only major peaks obtained in blood.

The internal standard, mannitol,

eluted between the a- and g-glucose peaks, and all 3 peaks were well
resolved.

Samples prepared without the internal standard showed no

peaks eluting at the same time as derivatized mannitol.
Optimization of gas chromatograph column flow rate.

The optimal

flow rate for the 1/8" x 6 ' SE-30 column was determined using
derivatized arabinose.

Fig. 24 shows the theoretical plate height

and retention time as a function of flow rate (varied
from 6.8 to 45.5 ml/min).

The theoretical plate height was calculated

from (139):
Height - 6/(16 ( f )2)
where x is the retention volume, and y is the peak volume.

A minimum

height was not achieved, therefore a flow rate of 20 ml/min was used
in further studies, as this represented a compromise between mln-fmum
theoretical plate height and retention time.
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FIG. 22.
of In(a

u

Change In optical rotation of glucose with time.

A plot

- a ) was made, and the value for an was determined by
00

extrapolation.

U

Optical purity was determined by comparison of 01q

with literature values for a-D-glucose (112°) or B-D-glucose (18.7°).
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SPECIFIC ROTATION

(DEGREES)

100

80

a-glucose

60

rotation after 24 hrs

40

20

/3- glucose

20

30

TIME (min)

40

TABLE VIII
POLARIMETRIC DETERMINATION OF OPTICAL PURITY OF a- AND 8-D-GLUCOSE
Sample

Anomer

weight (g)

observed rotation

specific rotation

a

optical purity
(per cent)

1.

a

2.4685

2.71

2.60

107.82

98.1

2.

a

2.5075

2.83

2.66

109.45l

98.5
98.3 Average

3.

8

2.6346

1.72

2.78

20.02

96.5

4.

8

2.5136

1.64

2.64

19.97

96.6
96.6 Average
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FIG. 23.

Gas chromatographic analysis of anomeric composition of

rat blood glucose.

The column (3 per cent SE-30 on Chromsorb W(HP))

was programmed from 165 to 175°C at 0.5°C/min.
follows:

The peaks are as

a, a-glucose; 11.88 min; b, mannitol (internal standard),

14.65 min; c, 6~glucose, 17.24 min; and d, 250°C column flush
(5 min).

8.75

9.60
ir.88

14.65

o

cr
17.24 o

O

c

21.64
22.59 Q27.
86A

FIG. 24.

Change in theoretical plate height with increase

in column (nitrogen) flow rate.

Arabinose (1.6 mg) was derivatized

as described in METHODS, and 1 yl was injected into the gas
chromatograph for each column flow rate shown.

— HEIGHT OF THEORETICAL PLATE
(ft X 10-3)

o

FLOW RATE (ml/min)

IV)

o

OJ

o

RETENTION TIME (min)

V£8
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Optimization of flame ionization detector flow rates.

Column

flow rate (nitrogen) was held constant at 20 ml/min, as hydrogen
(flame ionization detector) was varied from 6 to 30 ml/min, and air
was varied from 15 to 30 ml/min.

Hie peak area was measured when

1 yl of derivatized arabinose (1 mg, as described in METHODS) was
injected onto an isothermal (165°C) column.

Figs. 25 and 26 show

an increase in detector response when the ratio of air to hydrogen
was increased.

From these data, the optimal air and hydrogen flow

rates were 25 and 15 ml/min, respectively.
Time required for derivatization of glucose containing samples.
Glucose samples (1 mg) were derivatized and injected into the gas
chromatograph at timed intervals following derivatization.

Fig. 27

shows the area under the a-glucose curve to reach a maximum at 5 min.
Five minutes was required for the separation of the two phases so that
an analysis could be made.

Completion of the derivatization reaction

required less than 5 min.
Test for mutarotation of glucose during treatment of samples.
Glucose (3) was dissolved in ice cold methanol (90 per cent),
or equilibrated glucose samples were mixed with methanol, and
treated (sampled, lyophilized, and derivatized) as for blood glucose
samples.

Untreated 3-glucose and lyophilized equilibrated

glucose samples were derivatized to serve as controls.

Table IX

compares 8-glucose and equilibrated glucose samples which were
subjected to the "Preparation of blood samples" procedure versus
their untreated controls.

The results indicated no mutarotation

occurred during treatment of the 8-glucose, or of the equilibrated
glucose samples.

FIG.

25.

Optimization of flame ionization detector response:

Effect of variation in the ratio of air to hydrogen.

One mg of

D-arabinose was derivatized as described in METHODS, and 1 yl was
injected into the gas chromatograph for each combination of air and
hydrogen pressure shown.

Air pressure was varied from 15 to 40

pounds per square inch (psi), as hydrogen was varied from 6 to 30
psi.

AREA UNITS UNDER CURVE x 10

I

4

3

air pressure (psi)
x 20
o 25

2

35
a 40
k

1

2

air/ hydrogen

3

r a ti°

4

FIG. 26.

Optimization of flame ionization detector response.

The experimental data from Fig. 25 are plotted as a function of air
and hydrogen pressure (pounds per square inch, psi).

The numbers

on the graph refer to gas chromatograph area units x 10-^.

HYDROGEN

( p s i)

90A

30

20
3.3— 3.4 3.3
3.4— 3.4— 3.4— 3.4~

10

20

30

AIR ( p s i )

40

91

FIG. 27.

Determination of time required for derivatization of

glucose samples.

One mg samples of glucose were derivatized as

described in METHODS, and 1 pi aliquots were injected into the gas
chromatograph at timed intervals following derivitization, and again
after 24 hrs.

The detector response is plotted as area units at time

time = t, divided by area units (using the same sample) at time = »
(24 hrs).
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TABLE IX
EFFECT OF BLOOD SAMPLE PREPARATION
ON ANOMERIC COMPOSITION OF GLUCOSE SAMPLE
Each value Is the average of three determinations.
---------Per cent of anomer--------treated glucose*
Sample

8-glucose
glucose equilibrated

a

8

untreated (control)
a

2.69

97.31

2.64

97.36

38.82

61.18

38.76

61.24

in water

* as described in METHODS under ’’Preparation of blood samples”

Lower limit of detection of glucose anomers.

Sequential

dilutions (hexane) were made of the upper layer of a sample containing
derivatized glucose.

Aliquots of 5 yl of each dilution were analyzed

by gas chromatography.

Fig. 28, a plot of the log peak area (a-

glucose) versus log glucose (mg), shows that the determinations
were linear over the range of 0.002 - 1.0 mg of glucose.

At the

0.0002 mg level, background noise prevented accurate measurement,
and therefore the lower limit for analysis of glucose was 0.002
mg (blood samples routinely contained 0.05 - 0.25 mg of glucose).
Reliability of the eas chromatograph integrator.

Table X

compares the results of several experiments when the results were
obtained by gas chromatograph integration and by a "cut arid weigh"
procedure.

No significant differences (95 per cent confidence, by

student’s t-test) were found between the two procedures, indicating
correct integration by the gas chromatograph integrator.
Comparison of detector response for derivatized a- and 8-glucose
anomers.

Fig. 29 compares the gas chromatographic response for a

and 8~glucose versus the response obtained by nuclear magnetic
resonance spectroscopy.

A least squares analysis gave a slope of

1.05, indicating almost identical data obtained by these two
different techniques and lending credence to the reliability of the
method described here.
Partitioning of glucose and mannitol into the methanol layer
during preparation of blood samples.

During preparation of blood

samples, nearly all of the glucose and mannitol was partitioned
into the upper (methanol) layer (Table XI), in agreement with the
results of Miwa et al. (121).

Extraction of these two sugars was

FIG.

28.

Change in gas chromatograph detector response when the

amount of derivatized glucose injected was varied from 0.002 mg
(log = -2.7) to 1.0 mg (log = 0).
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TABLE X
COMPARISON OF GAS CHROMATOGRAPH RESULTS WHEN QUANTITATED
BY ELECTRONIC INTEGRATION VERSUS "CUT AND WEIGH"
------------ Per cent anomer + standard deviation ----Gas chromatograph integration

8

"Cut and weigh"

a

B

Trial 1.

37.70 +

0.56 62.27 + 0.55

37.10 + 0.88

62.90 + 0.88

Trial 2.

39.02 +

0.54 60.98 + 0.54

38.85 + 1.18

61.15 + 1.18

Trial 3.

37.03 +

0.93 62.97 + 0.93

38.20 + 1.17

61.81 + 1.17

FIG.

29.

Correlation of the anomeric composition of glucose sample

samples determined by gas chromatography with that obtained by
nuclear magnetic resonance spectroscopy.

Derivatized a- and fi-glucose

were mixed in various ratios, then analyzed by gas chromatography
(3 to 4 determinations per sample) and by nuclear magnetic resonance
(3 integrations per spectrum).
gives a slope of 1.05.

A least squares analysis of the data

% a

40
60
80

V96
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20
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TABLE XI
PARTITIONING OF GLUCOSE AND MANNITOL INTO THE UPPER PHASE OF THE EXTRACTION MIXTURE
Gas chromatograph area units x 10
Sample no.

a-glucose

(3-glucose

-4

mannitol

Upper layer (methanol)
1.

4.39

6.49

0.40

2.

5.28

7.75

2.60

3.

3.40

4.86

1.74

4.

4.04

5.99

2.18

Lower layer (chloroform)

1.

0.01

0.01

0.00

2.

0.00

0.00

0.00

3.

0.01

0.01

0.00

4.

0.00

0.00

0.01

quantitative.
Partitioning of derivatized glucose and mannitol into the upper
layer of the derivatizing mixture.

One yl of the upper layer of

a derivatized sample, or 10 yl of the lower (dimethylsulfoxide)
layer was tested by gas chromatographic analysis for the presence of
derivatized sugar.

Neither derivatized glucose or mannitol could

be detected in the dimethylsulfoxide phase (data not shown),
indicating complete partitioning of the derivatized sugar into the
upper layer.
Comparison of anomeric composition of glucose in blood at the
time of sacrifice and after 24 hrs.

The composition of blood glucose

anomers, when prepared and analyzed immediately after decapitation,
was equal to the anomeric composition of blood glucose when.the
blood was held at 23°C for 24 hrs (potassium fluoride was added to
inhibit glycolysis) (Table XII).
Analytical variability.

Aliquots of one rat blood glucose

sample (extracted, lyophilized, and derivatized as described in
METHODS) was injected 10 times into the gas chromatograph, and the
standard deviation of these analyses was calculated.

For comparison,

one analysis of each of 7 derivatized glucose samples (prepared
from the same rat blood sample) was made, and the standard deviation
of these data was calculated.

Table XIII shows that the variability

of the determinations among 7 different sample preparations was not
greater than the instrumental variability observed when one sample
was repeatedly analyzed, indicating that the precision of the sample
preparation was equal to or greater than the analytical (gas
chromatographic) precision.

TABLE XII
ANOMERIC COMPOSITION OF BLOOD GLUCOSE AT
SACRIFICE VERSUS AFTER 24 HR INCUBATION
Time of
sample preparation

Per cent of anomer + standard deviation
a

S

At sacrifice
(10 observations)

36.72 + 0.88

63.28'+_0.88

37.04 + 0.91

62.96 + 0.91

After 24 hrs
(3 observations)

TABLE XIII
COMPARISON OF STANDARD DEVIATIONS OF DETERMINATIONS:
ONE ANALYSIS OF EACH OF SEVEN BLOOD GLUCOSE PREPARATIONS
VERSUS TEN ANALYSES OF ONE PREPARATION

7 preparations

1 preparation

1 analysis each

10 analyses

a-glucose
Standard deviation
Mean

S-glucose

a-glucose 3-glucose

0.56

0.56

0.93

0.93

37.70

62.27

37.03

62.97

Comparison of anomeric composition of blood glucose from
normal and diabetic rats.

Table XIV shows the anomeric composition

of glucose in the blood of diabetic and normal rats to be close to
equilibrium, but favoring the $ anomer.

Normal rats did not

differ from each other in the fasted or fed states (student's ttest), and were not significantly different from diabetic rats.
However, all groups were significantly different from glucose
equilibrated in water, and diabetic fed rats were significantly
higher in the per cent of a anomer than diabetic fasted rats.
When normal or diabetic rats were treated with insulin, blood
glucose decreased by 54 and 62 per cent, respectively (Table XV).
The anomeric composition of blood remained close to equilibrium,
however, the blood of normal insulin-treated rats showed a
significantly lower per cent of 3-glucose over diabetic insulintreated rats or normal rats without insulin treatment.

TABLE XIV
COMPARISON OF ANOMERIC COMPOSITION OF BLOOD GLUCOSE OF NORMAL AND
DIABETIC RATS IN THE FASTED AND FED STATES

Per cent + standard deviation

Group

Total glucose
(mg/100 ml + SD)

a-glucose

3-glucose

fasted (24 hr)

37.1 + 0.4

62.9 + 0.4

fed

36.8 + 1.0

63.2 + 1.0

fasted (24 hr)

36.5 + 0.8

63.5 + 0.8*

98 + 15

fed

38.0 + 0.5

62.0 + 0.5*

443 + 69

Normal
83 + 13
109 +

8

Diabetic

a. All 4 groups were significantly different from 22 samples of glucoseequilibrated
(39.1 + 0.6 per cent a- and 10.9 + 0.6 per cent 8-glucose) by student's
level.

inwater

t-test at the p<0.05

The number of rats contained in the normal (fasted, fed) and diabetic (fasted, fed)

groups was 9, 8, 5, and 6, respectively.
b. Significantly different at p < 0 . 0 1 level by student's t-test.

TABLE XV
COMPARISON OF ANOMERIC COMPOSITION OF GLUCOSE IN WHOLE BLOOD AND PLASMA FROM
FED NORMAL AND DIABETIC RATS WITH OR WITHOUT INSULIN TREATMENT

Group

Per cent + standard deviation
a-glucose

8-glucose

Total glucose
(mg/100 ml + SD)

Normal (9 rats)
blood

36.9 + 1.0

63.1 + l.C

91 + 12

plasma

37.6 + 0.6

62.4 + 0.<

136 + 15

Normal + insulin (4 rats)
ab,c

42 + 13

blood

39.6 + 0.3

60.4 + 0.

insulin

39.2 + 0.7

60.8 + 0.

blood

38.1 + 0.6

61.9 + 0 .6c, e

460 + 97

plasma

38.5 + 0.9

61.5 + 0 .9e

685 + 96

60 + 12

Diabetic (6 rats)

Diabetic + insulin (5 rats)
blood

38.0 + 0.3

62.0 + 0 .3

175 + 45

plasma

38.5 + 0.2

61.5 + 0 .2

188 + 61
103

b,c, p <0.005; d,e, p <0.05 by student's t-test

DISCUSSION
The gas chromatographic method of measurement of glucose
anomers in biological fluids described in this report offers four
advantages over other procedures:

1)

it offers increased accuracy,

since anomerization of the sample cannot occur during analysis;
2)

since this procedure is not dependent on the reaction of glucose

(except for the derivatization), quantitation is not interfered
with by compounds in biological fluids (eg. ascorbic acid and
glutathione interfere with procedures using glucose oxidase); 3)
samples can be prepared, derivatized, and stored for later analysis
without the possibility of equilibration of the glucose anomers
during storage, thus facilitating the collection of samples; and 4)
it can be used for any saccharide which can be derivatized and is
present in sufficient concentration to be measured (eg. 2 yg per
sample for the conditions used in this investigation).
The data presented in this report show blood glucose to be
close to equilibrium for both diabetic and normal rats in t he
fed and fasted states.

This is in contrast to the conclusions of

Lundsgaard and Hoboll (133), who reported blood glucose of normal
humans to favor the 0-anomer, whereas blood glucose of diabetics
was at equilibrium.

Miwa et al. (121), using an oxygen electrode

procedure, also showed blood glucose to be close to equilibrium in
normal fasted rats, and blood glucose was shown to be close to
equilibrium in dogs (88).
104
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Many transport systems have shown a preference for one anomer
of sugars (86,96,97,99-102,107-110,113), and it was suggested that
one anomer may be preferentially metabolized in cells (102), thus
disturbing the equilibrium of blood glucose.

Passage of blood through

organs with high activity of mutarotase, such as liver (136) and
kidney (129), and the spontaneous mutarotation of glucose (131) tend
to reestablish the equilibrium.

The relative rates of disturbing

and reestablishing the equilibrium could determine the resulting
anomeric composition in blood.
Since some transport systems have been shown to be specific
for one anomer of glucose, insulin-facilitated entry of glucose into
cells could result in a disturbance of glucose equilibrium in blood.
Hill (88) showed no change in anomeric composition of blood glucose
in response to insulin administration, whereas Madreiter e£ al.
(96) reported an increase in the per cent of a-glucose upon
administration of insulin.

The procedure described here is able to

detect small differences in glucose anomeric composition, and confirms
a small, but statistically significant decrease in the per cent of
g-glucose when insulin is administered to normal fed rats.
While the precise metabolic significance of this decrease in
6-glucose in insulin treated normal rats is unknown, it may reflect
a preferential uptake of 8-glucose in response to insulin.
decrease in

A similar

6-glucose was not seen in the blood and plasma of

insulin treated diabetic animals, however the high levels of total
glucose in diabetic animals may have precluded the observation of
a change in the relative concentration of glucose anomers.
Further possible explanations for the data in this report

involve a preferential binding of g-glucose by saturable glucosebinding component(s) of blood.

Glucose equilibrated in water

contained 39 per cent a- and 61 per cent 3-glucose, whereas glucose
extracted from the blood of fed or fasted normal rats, or fasted
diabetic rats favored the 3 anomer (37 per cent a-glucose and 63 per
cent 3-glucose).

This represented the equilibrium composition of

glucose in the blood of these animals, since incubation of blood at
room temperature for 24 hrs did not alter the anomeric composition
of glucose in the blood.

The analytical method used in this inves

tigation did not distinguish between bound and free glucose, and
therefore would quantitate the total of bound and free glucose.
a-glucose
(bound)

a-glucose
(free)

-*•
*■

3-glucose
(free)

«-

3-glucose
(bound)

A stronger binding of 3-glucose by the glucose binding component(s)
would shift the above relationship to the right.

Thus, an equilibrium

favoring the 3 anomer of glucose would be apparent.

This effect

would not be as distinct in the blood of the diabetic groups because
of the high levels of total blood glucose.

In fact, the anomeric

composition of glucose from blood of diabetic animals would be
expected to approach that of glucose equilibrated in water, as was
found in this study.

The anomeric composition of glucose in plasma

from normal rats favored the 3 anomer, as did the glucose composition
in whole blood, and therefore, the saturable glucose binding
component(s) would be located in the plasma.

The existence of these

glucose binding component(s) has yet to be demonstrated, however.
The data in this report, as in other studies, show a persistence
in the tendency of blood glucose to be close to equilibrium under

various metabolic conditions.

The anomeric specificity of the

glucose receptors of the pancreas suggests that the regulation of
blood glucose anomeric composition is important for the maintainance
of metabolic homeostasis.

On the other hand, the demonstration of

anomer specific transport systems suggests that increased transport
activity could cause blood glucose to deviate from equilibrium.
These observations suggest that mutarotase may be essential for the
maintainance of metabolic homeostasis by keeping the a- and $glucose anomers of blood near to, or at equilibrium.

This role for

mutarotase is supported by Hill’s demonstration of a slow equilibration
of blood glucose anomers when a- or ^-glucose was infused intra
venously, and blood was not passed through organs of high mutarotase
activity (88).

CHAPTER III.

NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY OF BLOOD CELLS
AND BLOOD SERUM FROM NORMAL AND DIABETIC RATS
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INTRODUCTION

Glycolytic rates have historically been measured by the
accumulation of lactate, using methods which require destruction
of the cell.

The technique of nuclear magnetic resonance has found

value in the field of biochemistry in that it provides a non
invasive method of monitoring cellular metabolism.
13

C and

31

Pertinently,

P nuclear magnetic spectroscopy has been used to follow

the course of metabolic intermediates in living cells (140).

Proton

magnetic resonance of protein containing cells has given
spectra that are too complex to be useful in the measurement
of metabolic intermediates.

However, the recent development of

multiple pulse techniques has provided sufficient simplification
of proton spectra that the in vivo accumulation of metabolic
intermediates can be detected.
The objective of this study was to use proton magnetic resonance
to observe the in vivo accumulation of lactate in normal and diabetic
cells.

Red blood cells were used because of their relatively simple

composition.

Glycolytic activity was begun by the addition of

glucose to cells, however, glycolysis could also be initiated at the
glyceraldehyde 3-phosphate dehydrogenase (E.C. 1.2.1.12) step with
the addition of dihydroxyacetone (141).

Alternatively, glycolytic

activity could be terminated by the addition of glycolysis inhibitors,
and in this manner, the technique described here could aid in the
characterization of new inhibitors of glycolysis.
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Spin echo techniques for the simplification of protein spectra
have been studied by Campbell et al_. (142) and Brown et al. (143) .
A 90° - t - 180° - t - FID sequence (where t “ delay time, and
FID represents collection of the free induction decay data)
simplifies the spectra of red blood cells because a) the nuclei

of

slow moving components tend to relax in the 2t delay period following
the 90° pulse; and b) the delay period between the 90° and 180°
pulses (t ) allows nuclei

in the inhomogeneous magnetic environment

outside the blood cells to lose phase with each other (144).

Thus

the spin echo spectrum consists primarily of freely moving
components located in the interior of the blood cell.
Brindle et al. (144) have taken advantage of the properties of
spin echo nuclear magnetic resonance to measure membrane transport
of D- and L-alanine

and lactate in the red blood cell, and Brown

et al. (143) have used spin echo to measure the red cell's internal
pH.

Campbell et al_. (142) simplified the spectra of lysozyme and

hemoglobin by spin echo techniques, and spin echo has been used to
demonstrate the mobility of epinephrine in storage vesicles of the
adrenal gland (145).
This report gives the conditions which have been developed
for the measurement of in vivo glycolytic rates, using spin echo
proton magnetic resonance.

Experimental results, using blood from

normal and diabetic rats, show that under the conditions used, no
differences were seen in the rates of lactate accumulation.

Blood

serum from normal and diabetic rats was also examined, using normal
proton magnetic resonance.

The serum from diabetic rats showed

higher levels of glucose than did the serum of normal rats, but

other differences were not apparent.

METHODS

Preparation of red blood cells.

Heparinized rat blood was

measured into Eppendorf centrifuge tubes (1.5 ml of blood
per tube) and centrifuged in an Eppendorf, model 5412 centrifuge
at 13,000 x g for 2.5 min (0 - 4°C).

The serum was removed, and the

cells were washed with 0.9 per cent saline in D£0 (twice), and with
Krebs-Ringer buffer (145), pH 7.4, made up in D2O (twice).

Just

before the experiment, cells were centrifuged, warmed to 30°C, and
resuspended, by vortex, with 100 yl (15 per cent of volume) of
Krebs Ringer buffer, pH 7.4 ^ O ) , with or without 50 mM glucose
(final concentration, 7.5 mM) .

Cells resuspended in this manner

did not settle during the experiment.

Cells were used within

4 hrs of collection, and the temperature was held at 30°C throughout
the spectroscopy.
Preparation of rat blood serum.

Blood from two rats was pooled

and centrifuged for 25 min at 9500 x g at room temperature.

The

serum was collected and diluted 1/1 (v/v) with D2O, and lyophilized
(twice).

The dried serum was resuspended in D2O for analysis.

Nuclear magnetic spectroscopy. Measurements were on a Bruker
WP-200 spectrometer, with chemical shifts relative to external
3-(trimethylsilyl)propionic acid (sodium).

Pulse widths for normal

spectra were typically 2.5 psec, with a 0.5 sec relaxation delay.
Data points (2000 - 8000 for normal spectra and 2000 for spin echo)
were collected over 2000 hertz, with a 0.5 - 2.1 sec aquisition time
112

(the shorter times were used for spin echo).

Samples were in

5 mm tubes, with spinning.
Spin echo techniques were from the methods of Campbell et^ al.
(142), using a 90° - t - 180° - x - FID pulse sequence.

Usually 15

spectra were taken over a 3 hr period, and stored on a disk.

The

intensity of the lactate methyl peak was normalized to the external
standard (above).

Signal to noise was enhanced by use of an

exponential multiplier function applied to the free induction decay.

RESULTS

Spin echo experiments.

Hie success of the spin echo experiment

depends, in part, on achieving the correct pulse angle (90°).
The correctness of the experimental parameters was tested by
observing the lactate methyl resonance (doublet) at various values
of the delay time, t (Fig. 30).

From reference 144

the doublet

should be inverted when 2t ° 1/J, where J is the coupling constant,
and should be in phase when t = 1/J.

Fig. 30 shows the behavior

of the lactate methyl resonance to be as predicted, indicating
correctness of the experimental parameters.

(In blood cell

experiments, the lactate methyl resonance was not a doublet, since
lactate was produced by the reduction of pyruvate with deuterated
NADH, and therefore was not inverted, as described above.)
Fig. 31 illustrates the complexity of a normal proton magnetic
resonance spectrum of rat red blood cells.

The spectrum of red

blood cells was simplified by spin echo, as shown in Fig. 32,
allowing visualization of the lactate methyl resonance (1.26 ppm).
This resonance was clearly resolved when a t value of 60 msec was
used, since only a few resonances were visible in the spin echo
spectrum.

The intensity of the lactate peak increased in a linear

fashion over the 151 min of the experiment (Fig. 32).

The

accumulation of lactate in red blood cells from normal rats
was compared with that of cells from diabetic rats (Fig. 33).
No differences in the rates of production of lactate were seen
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FIG. 30.

Illustration of change of phase of lactate methyl

resonance (doublet) with increasing values of t . The values of t
were a) 0.036 sec; b) 0.072 sec; c) 0.108 sec; and d) 0.144 sec.
The coupling constant (J) of the doublet was 6.96 hertz (1/J »
0.144 sec), and a 90° - t - 180° - t - FID pulse sequence was used.
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FIG. 31.

Proton magnetic resonance spectrum of red blood cells.

Cells were prepared as described in METHODS, and resuspended in
Krebs Ringer buffer without glucose.

Data points (2000) were

collected over 2000 hertz (48 scans), with a 0.51 sec aquisition
time, and a 2.5 ysec pulse width.
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FIG. 32.

Spin echo proton magnetic resonance of red blood cells

at 3 - 151 min after the addition of glucose to washed cells.

The

concentration of glucose was 7.5 mM, and the temperature was held
constant at 30°C.

A 90° - x - 180° - x - FID (90° = 14.5 ysec,

x = 0.060 sec) pulse sequence was used, with a 0.5 sec relaxation
delay.

Data points (2000) were collected over 2000 hertz, and the

ratio of signal to noise was enhanced by the use of an exponential
multiplication function (maximum line broadening of 3 hertz).
The entire spectrum was negated here to display the reference peak
in an upright position.

The actual positions of the lactate and

reference peaks were upright and inverted, respectively.
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FIG. 33.

Increase in concentration of lactate in red blood cells

from normal and diabetic rats, determined by the non-invasive
technique of spin echo nuclear magnetic resonance.

The intensity

of the lactate methyl resonance was normalized to the intensity
of the external standard peak.
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between the two groups in these experiments.
Serum from normal and diabetic animals.

Fig. 34 shows the

normal proton magnetic resonance spectra from normal and
diabetic animals.

Assignments of prominent peaks were made by

comparison of the spectra with published data on serum lipoproteins
(147-149).

The spectrum of serum from diabetic rats had an

increased intensity for the resonances in the 3 - 4

ppm region, due

to serum glucose, but no other major differences between the two
groups were apparent.

FIG. 34.

Proton magnetic resonance spectra of serum from diabetic

(upper trace), and normal (lower trace) rats.

Scans (100) were

collected, using 8000 data points over 2000 hertz, with a 2.04 sec
aquisition time.

The temperature was held at 30°C.
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DISCUSSION
Using spin echo techniques, the lactate methyl resonance was
clearly resolved.

Since few other resonances were apparent, the

addition of inhibitors of glycolysis would allow the detection
of specific glycolytic intermediates which would build up due to
the presence of the inhibitor (provided they do not fall too near,
or under the signal due to water).

liius, this technique could aid

in the characterization of inhibitors of glycolysis.
No differences were seen in the rates of in vivo accumulation
of lactate in red blood cells from normal and diabetic rats.
Differences might be apparent if insulin were added to the cells,
since many cell types from diabetic animals have increased
numbers, of insulin receptors (150).

Alternatively, cell membranes may

have been damaged in the cell preparation process.
Blood serum o f .streptozotocin diabetic rats is known to be high
in endogenous and exogenous lipoproteins (151).

Although serum

lipoproteins have been purified and characterized by proton magnetic
resonance (147-149)* it is difficult to evaluate the serums for
qualitative differences in the lipoproteins, since many of the lipid
constituents are common to all lipoprotein classes.

Nuclear magnetic

resonance spectroscopy is able to detect differences in the structure
of lipoproteins (147-149), since binding of lipids to proteins can
alter the degree of freedom experienced by the lipid.

No differences

in the structure of lipoproteins in serum of normal and diabetic
121
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rats were apparent.
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APPENDIX
List of abbreviations
PFK

phosphofructokinase

SD

standard deviation

S.E.M. standard error of the mean
m

male

f

female

FID

free induction decay

J

coupling constant

x

time delay
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